ONTOLOGY REPORT - ANNOTATIONS
|
||||||||||||||||||||||||||||
raloxifene
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | Aatk | apoptosis-associated tyrosine kinase |
|
increases expression | EXP | 10 | 109,419,819 | 109,456,182 | RGD:6480464 | CTD | |
| G | Abcb1a | ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
affects activity | ISO | 4 | 21,709,855 | 21,796,628 | RGD:6480464 | CTD | |
| G | Abcb1a | ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions | ISO | 4 | 21,709,855 | 21,796,628 | RGD:6480464 | CTD | |
| G | Abcb1a | ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases expression | ISO | 4 | 21,709,855 | 21,796,628 | RGD:6480464 | CTD | |
| G | Abcb9 | ATP-binding cassette, subfamily B (MDR/TAP), member 9 |
|
affects expression | ISO | 12 | 33,623,383 | 33,656,242 | RGD:6480464 | CTD | |
| G | Abcc1 | ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions | ISO | 10 | 452,239 | 575,705 | RGD:6480464 | CTD | |
| G | Abcg1 | ATP-binding cassette, subfamily G (WHITE), member 1 |
|
affects expression | ISO | 20 | 9,390,485 | 9,459,574 | RGD:6480464 | CTD | |
| G | Abhd5 | abhydrolase domain containing 5 |
|
affects expression | ISO | 8 | 122,148,937 | 122,173,147 | RGD:6480464 | CTD | |
| G | Ablim3 | actin binding LIM protein family, member 3 |
|
affects expression | ISO | 18 | 57,781,588 | 57,900,968 | RGD:6480464 | CTD | |
| G | Ace | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
decreases expression | ISO | 10 | 95,361,338 | 95,381,455 | RGD:6480464 | CTD | |
| G | Acsl1 | acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions | ISO | 16 | 49,036,892 | 49,081,416 | RGD:6480464 | CTD | |
| G | Acvrl1 | activin A receptor type II-like 1 |
|
increases expression | ISO | 7 | 139,873,596 | 139,884,675 | RGD:6480464 | CTD | |
| G | Adam19 | ADAM metallopeptidase domain 19 |
|
multiple interactions | ISO | 10 | 31,190,242 | 31,282,773 | RGD:6480464 | CTD | |
| G | Adam22 | ADAM metallopeptidase domain 22 |
|
decreases expression | ISO | 4 | 22,332,086 | 22,507,086 | RGD:6480464 | CTD | |
| G | Adamtsl3 | ADAMTS-like 3 |
|
affects expression | ISO | 1 | 138,563,870 | 138,876,886 | RGD:6480464 | CTD | |
| G | Adcy2 | adenylate cyclase 2 (brain) |
|
affects expression | EXP | 17 | 4,543,466 | 5,040,433 | RGD:6480464 | CTD | |
| G | Adcyap1 | adenylate cyclase activating polypeptide 1 | affects expression | EXP | RGD:6480464 | CTD | |||||
| G | Adh1 | alcohol dehydrogenase 1 (class I) |
|
increases expression | EXP | 2 | 235,799,396 | 235,811,584 | RGD:6480464 | CTD | |
| G | Adipoq | adiponectin, C1Q and collagen domain containing |
|
increases expression | ISO | 11 | 79,908,291 | 79,911,065 | RGD:6480464 | CTD | |
| G | Adora2a | adenosine A2a receptor |
|
increases expression | ISO | 20 | 13,815,719 | 13,834,131 | RGD:6480464 | CTD | |
| G | Adora2b | adenosine A2B receptor |
|
multiple interactions | ISO | 10 | 48,421,592 | 48,437,967 | RGD:6480464 | CTD | |
| G | Adra1a | adrenoceptor alpha 1A |
|
decreases expression | EXP | 15 | 46,173,429 | 46,263,198 | RGD:6480464 | CTD | |
| G | Aebp1 | AE binding protein 1 |
|
increases expression | EXP | 14 | 86,525,748 | 86,535,664 | RGD:6480464 | CTD | |
| G | Ago2 | argonaute RISC catalytic component 2 |
|
affects expression | ISO | 7 | 110,827,857 | 110,865,589 | RGD:6480464 | CTD | |
| G | Ago2 | argonaute RISC catalytic component 2 |
|
multiple interactions | ISO | 7 | 110,827,857 | 110,865,589 | RGD:6480464 | CTD | |
| G | Agt | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions | ISO | 19 | 54,738,556 | 54,750,349 | RGD:6480464 | CTD | |
| G | Ahcyl1 | adenosylhomocysteinase-like 1 |
|
affects expression | ISO | 2 | 203,210,376 | 203,244,218 | RGD:6480464 | CTD | |
| G | Ahnak | AHNAK nucleoprotein |
|
decreases expression | ISO | 1 | 211,662,523 | 211,692,558 | RGD:6480464 | CTD | |
| G | Ahr | aryl hydrocarbon receptor |
|
multiple interactions | ISO | 6 | 54,205,104 | 54,240,268 | RGD:6480464 | CTD | |
| G | Ak3 | adenylate kinase 3 |
|
affects expression | EXP | 1 | 232,658,879 | 232,684,083 | RGD:6480464 | CTD | |
| G | Akap1 | A kinase (PRKA) anchor protein 1 |
|
affects expression | ISO | 10 | 77,262,592 | 77,276,832 | RGD:6480464 | CTD | |
| G | Akap1 | A kinase (PRKA) anchor protein 1 |
|
multiple interactions | ISO | 10 | 77,262,592 | 77,276,832 | RGD:6480464 | CTD | |
| G | Akr7a2 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
|
affects expression | EXP | 5 | 158,097,679 | 158,106,217 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation | ISO | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation | ISO | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Akt1 | v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation | EXP | 6 | 137,640,482 | 137,657,552 | RGD:6480464 | CTD | |
| G | Alas2 | aminolevulinate, delta-, synthase 2 | affects expression | EXP | RGD:6480464 | CTD | |||||
| G | Alcam | activated leukocyte cell adhesion molecule |
|
multiple interactions | ISO | 11 | 49,424,243 | 49,630,071 | RGD:6480464 | CTD | |
| G | Amigo2 | adhesion molecule with Ig like domain 2 |
|
multiple interactions | ISO | 7 | 135,966,794 | 135,969,747 | RGD:6480464 | CTD | |
| G | Amotl2 | angiomotin like 2 |
|
affects expression | ISO | 8 | 107,694,405 | 107,709,841 | RGD:6480464 | CTD | |
| G | Ang | angiogenin, ribonuclease, RNase A family, 5 |
|
increases expression | ISO | 15 | 27,083,089 | 27,083,526 | RGD:6480464 | CTD | |
| G | Angptl2 | angiopoietin-like 2 |
|
affects expression | ISO | 3 | 12,226,515 | 12,256,396 | RGD:6480464 | CTD | |
| G | Angptl7 | angiopoietin-like 7 |
|
decreases expression | ISO | 5 | 165,579,768 | 165,583,680 | RGD:6480464 | CTD | |
| G | Ank3 | ankyrin 3, node of Ranvier (ankyrin G) |
|
affects expression | EXP | 20 | 19,328,684 | 19,828,196 | RGD:6480464 | CTD | |
| G | Ankrd1 | ankyrin repeat domain 1 |
|
multiple interactions | ISO | 1 | 240,316,123 | 240,324,804 | RGD:6480464 | CTD | |
| G | Ankrd28 | ankyrin repeat domain 28 |
|
multiple interactions | ISO | 16 | 7,166,559 | 7,248,739 | RGD:6480464 | CTD | |
| G | Aox1 | aldehyde oxidase 1 |
|
multiple interactions | ISO | 9 | 56,693,698 | 56,774,115 | RGD:6480464 | CTD | |
| G | Aox1 | aldehyde oxidase 1 |
|
decreases activity | ISO | 9 | 56,693,698 | 56,774,115 | RGD:6480464 | CTD | |
| G | Ap1g1 | adaptor-related protein complex 1, gamma 1 subunit |
|
affects expression | ISO | 19 | 39,676,021 | 39,734,854 | RGD:6480464 | CTD | |
| G | Apex1 | APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression | EXP | 15 | 26,904,124 | 26,906,224 | RGD:6480464 | CTD | |
| G | Apex1 | APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
multiple interactions | EXP | 15 | 26,904,124 | 26,906,224 | RGD:6480464 | CTD | |
| G | Apod | apolipoprotein D | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Ar | androgen receptor |
|
decreases expression | ISO | X | 85,949,507 | 86,119,199 | RGD:6480464 | CTD | |
| G | Ar | androgen receptor |
|
decreases expression | EXP | X | 85,949,507 | 86,119,199 | RGD:6480464 | CTD | |
| G | Ar | androgen receptor |
|
decreases expression | EXP | X | 85,949,507 | 86,119,199 | RGD:6480464 | CTD | |
| G | Areg | amphiregulin |
|
decreases expression | ISO | 14 | 18,466,313 | 18,475,571 | RGD:6480464 | CTD | |
| G | Areg | amphiregulin |
|
multiple interactions | ISO | 14 | 18,466,313 | 18,475,571 | RGD:6480464 | CTD | |
| G | Areg | amphiregulin |
|
multiple interactions | ISO | 14 | 18,466,313 | 18,475,571 | RGD:6480464 | CTD | |
| G | Areg | amphiregulin |
|
increases expression | ISO | 14 | 18,466,313 | 18,475,571 | RGD:6480464 | CTD | |
| G | Arhgap29 | Rho GTPase activating protein 29 |
|
affects expression | ISO | 2 | 218,619,428 | 218,679,087 | RGD:6480464 | CTD | |
| G | Arid5a | AT rich interactive domain 5A (Mrf1 like) |
|
multiple interactions | ISO | 9 | 35,239,813 | 35,244,452 | RGD:6480464 | CTD | |
| G | Arid5b | AT rich interactive domain 5B (Mrf1 like) |
|
affects expression | ISO | 20 | 21,122,734 | 21,307,034 | RGD:6480464 | CTD | |
| G | Arl1 | ADP-ribosylation factor-like 1 |
|
affects expression | EXP | 7 | 25,403,921 | 25,416,168 | RGD:6480464 | CTD | |
| G | Arl4c | ADP-ribosylation factor-like 4C |
|
affects expression | ISO | 9 | 87,617,584 | 87,663,028 | RGD:6480464 | CTD | |
| G | Arl4c | ADP-ribosylation factor-like 4C |
|
multiple interactions | ISO | 9 | 87,617,584 | 87,663,028 | RGD:6480464 | CTD | |
| G | Arnt2 | aryl hydrocarbon receptor nuclear translocator 2 |
|
increases expression | ISO | 1 | 140,535,823 | 140,646,838 | RGD:6480464 | CTD | |
| G | Asb13 | ankyrin repeat and SOCS box-containing 13 |
|
multiple interactions | ISO | 17 | 77,759,058 | 77,777,760 | RGD:6480464 | CTD | |
| G | Asns | asparagine synthetase (glutamine-hydrolyzing) |
|
decreases expression | ISO | 4 | 32,758,866 | 32,776,220 | RGD:6480464 | CTD | |
| G | Atf3 | activating transcription factor 3 |
|
multiple interactions | ISO | 13 | 107,191,622 | 107,223,850 | RGD:6480464 | CTD | |
| G | Atf3 | activating transcription factor 3 |
|
increases expression | ISO | 13 | 107,191,622 | 107,223,850 | RGD:6480464 | CTD | |
| G | Atf7ip | activating transcription factor 7 interacting protein |
|
increases expression | ISO | 4 | 173,566,920 | 173,586,494 | RGD:6480464 | CTD | |
| G | Atp1a1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
affects expression | EXP | 2 | 196,657,749 | 196,687,242 | RGD:6480464 | CTD | |
| G | Atp9a | ATPase, class II, type 9A | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Aurka | aurora kinase A |
|
decreases expression | ISO | 3 | 163,270,479 | 163,284,506 | RGD:6480464 | CTD | |
| G | Bad | BCL2-associated agonist of cell death |
|
increases cleavage | ISO | 1 | 209,617,373 | 209,626,292 | RGD:6480464 | CTD | |
| G | Bai2 | brain-specific angiogenesis inhibitor 2 |
|
affects expression | ISO | 5 | 149,014,053 | 149,046,244 | RGD:6480464 | CTD | |
| G | Bak1 | BCL2-antagonist/killer 1 |
|
decreases expression | ISO | 20 | 5,255,954 | 5,264,593 | RGD:6480464 | CTD | |
| G | Bax | Bcl2-associated X protein |
|
affects expression | ISO | 1 | 95,933,023 | 95,938,176 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
affects expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
decreases expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
increases expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
decreases expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
decreases expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
decreases expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
decreases expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
decreases expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2 | B-cell CLL/lymphoma 2 |
|
decreases expression | ISO | 13 | 12,730,736 | 12,905,108 | RGD:6480464 | CTD | |
| G | Bcl2l11 | BCL2-like 11 (apoptosis facilitator) |
|
increases expression | ISO | 3 | 115,692,323 | 115,722,701 | RGD:6480464 | CTD | |
| G | Bcl3 | B-cell CLL/lymphoma 3 |
|
multiple interactions | ISO | 1 | 79,122,801 | 79,137,035 | RGD:6480464 | CTD | |
| G | Bcl6 | B-cell CLL/lymphoma 6 |
|
increases expression | ISO | 11 | 79,006,123 | 79,030,555 | RGD:6480464 | CTD | |
| G | Bglap | bone gamma-carboxyglutamate (gla) protein |
|
decreases expression | ISO | 2 | 180,482,313 | 180,483,290 | RGD:6480464 | CTD | |
| G | Bgn | biglycan |
|
increases expression | ISO | X | 159,380,557 | 159,393,409 | RGD:6480464 | CTD | |
| G | Bgn | biglycan |
|
increases expression | EXP | X | 159,380,557 | 159,393,409 | RGD:6480464 | CTD | |
| G | Birc3 | baculoviral IAP repeat-containing 3 |
|
multiple interactions | ISO | 8 | 4,682,202 | 4,696,856 | RGD:6480464 | CTD | |
| G | Blzf1 | basic leucine zipper nuclear factor 1 |
|
decreases expression | ISO | 13 | 80,057,361 | 80,073,350 | RGD:6480464 | CTD | |
| G | Bmp7 | bone morphogenetic protein 7 |
|
affects expression | ISO | 3 | 163,723,429 | 163,799,567 | RGD:6480464 | CTD | |
| G | C1qb | complement component 1, q subcomponent, B chain |
|
affects expression | EXP | 5 | 155,647,524 | 155,653,074 | RGD:6480464 | CTD | |
| G | C2cd2 | C2 calcium-dependent domain containing 2 |
|
affects expression | ISO | 11 | 37,873,369 | 37,935,054 | RGD:6480464 | CTD | |
| G | C2cd2 | C2 calcium-dependent domain containing 2 |
|
multiple interactions | ISO | 11 | 37,873,369 | 37,935,054 | RGD:6480464 | CTD | |
| G | C3 | complement component 3 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cabin1 | calcineurin binding protein 1 |
|
increases expression | EXP | 20 | 13,444,801 | 13,569,453 | RGD:6480464 | CTD | |
| G | Cacna1h | calcium channel, voltage-dependent, T type, alpha 1H subunit |
|
decreases expression | ISO | 10 | 14,621,372 | 14,679,051 | RGD:6480464 | CTD | |
| G | Cacna1i | calcium channel, voltage-dependent, T type, alpha 1I subunit |
|
decreases expression | ISO | 7 | 118,582,279 | 118,681,537 | RGD:6480464 | CTD | |
| G | Calb2 | calbindin 2 |
|
increases expression | ISO | 19 | 40,023,072 | 40,051,150 | RGD:6480464 | CTD | |
| G | Cald1 | caldesmon 1 |
|
decreases expression | ISO | 4 | 62,087,364 | 62,156,855 | RGD:6480464 | CTD | |
| G | Calm1 | calmodulin 1 |
|
multiple interactions | ISO | 6 | 124,477,601 | 124,485,669 | RGD:6480464 | CTD | |
| G | Cap2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | decreases expression | EXP | RGD:6480464 | CTD | |||||
| G | Capn2 | calpain 2, (m/II) large subunit |
|
affects expression | ISO | 13 | 98,473,367 | 98,524,463 | RGD:6480464 | CTD | |
| G | Car12 | carbonic anyhydrase 12 |
|
affects expression | ISO | 8 | 71,017,732 | 71,070,729 | RGD:6480464 | CTD | |
| G | Car12 | carbonic anyhydrase 12 |
|
multiple interactions | ISO | 8 | 71,017,732 | 71,070,729 | RGD:6480464 | CTD | |
| G | Car4 | carbonic anhydrase 4 |
|
affects expression | EXP | 10 | 73,229,211 | 73,237,707 | RGD:6480464 | CTD | |
| G | Card10 | caspase recruitment domain family, member 10 |
|
affects expression | ISO | 7 | 116,737,928 | 116,766,959 | RGD:6480464 | CTD | |
| G | Caskin2 | cask-interacting protein 2 |
|
multiple interactions | ISO | 10 | 105,901,164 | 105,915,318 | RGD:6480464 | CTD | |
| G | Casp3 | caspase 3 |
|
increases expression | ISO | 16 | 48,944,226 | 48,962,420 | RGD:6480464 | CTD | |
| G | Casp7 | caspase 7 |
|
affects expression | ISO | 1 | 262,689,300 | 262,721,591 | RGD:6480464 | CTD | |
| G | Casp7 | caspase 7 |
|
multiple interactions | ISO | 1 | 262,689,300 | 262,721,591 | RGD:6480464 | CTD | |
| G | Cat | catalase |
|
increases activity | ISO | 3 | 88,654,077 | 88,686,212 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
multiple interactions | EXP | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
affects expression | ISO | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cav1 | caveolin 1, caveolae protein |
|
increases expression | EXP | 4 | 42,956,102 | 42,989,057 | RGD:6480464 | CTD | |
| G | Cbx1 | chromobox homolog 1 |
|
decreases expression | ISO | 10 | 85,544,537 | 85,564,903 | RGD:6480464 | CTD | |
| G | Cbx3 | chromobox homolog 3 |
|
decreases expression | ISO | 4 | 79,707,325 | 79,720,100 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
multiple interactions | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
affects expression | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
multiple interactions | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl2 | chemokine (C-C motif) ligand 2 |
|
decreases activity | ISO | 10 | 70,256,263 | 70,258,061 | RGD:6480464 | CTD | |
| G | Ccl20 | chemokine (C-C motif) ligand 20 |
|
multiple interactions | ISO | 9 | 82,440,965 | 82,443,542 | RGD:6480464 | CTD | |
| G | Ccl20 | chemokine (C-C motif) ligand 20 |
|
affects expression | ISO | 9 | 82,440,965 | 82,443,542 | RGD:6480464 | CTD | |
| G | Ccl3 | chemokine (C-C motif) ligand 3 |
|
multiple interactions | ISO | 10 | 71,744,559 | 71,746,109 | RGD:6480464 | CTD | |
| G | Ccl3 | chemokine (C-C motif) ligand 3 |
|
decreases expression | ISO | 10 | 71,744,559 | 71,746,109 | RGD:6480464 | CTD | |
| G | Ccl5 | chemokine (C-C motif) ligand 5 |
|
decreases expression | ISO | 10 | 71,605,791 | 71,610,330 | RGD:6480464 | CTD | |
| G | Ccna2 | cyclin A2 |
|
increases expression | ISO | 2 | 123,062,752 | 123,069,085 | RGD:6480464 | CTD | |
| G | Ccnb1 | cyclin B1 |
|
increases expression | ISO | 2 | 31,574,600 | 31,581,784 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
affects expression | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccnd1 | cyclin D1 |
|
multiple interactions | ISO | 1 | 205,357,235 | 205,366,757 | RGD:6480464 | CTD | |
| G | Ccng2 | cyclin G2 |
|
increases expression | ISO | 14 | 16,338,132 | 16,346,628 | RGD:6480464 | CTD | |
| G | Cd200 | Cd200 molecule |
|
decreases expression | EXP | 11 | 56,946,504 | 56,974,256 | RGD:6480464 | CTD | |
| G | Cd24 | CD24 molecule |
|
increases expression | ISO | 20 | 47,502,354 | 47,507,663 | RGD:6480464 | CTD | |
| G | Cd3g | CD3 molecule, gamma |
|
affects expression | EXP | 8 | 47,924,369 | 47,930,550 | RGD:6480464 | CTD | |
| G | Cd40 | CD40 molecule, TNF receptor superfamily member 5 |
|
multiple interactions | ISO | 3 | 156,092,602 | 156,107,427 | RGD:6480464 | CTD | |
| G | Cd74 | Cd74 molecule, major histocompatibility complex, class II invariant chain |
|
affects expression | EXP | 18 | 56,756,511 | 56,765,711 | RGD:6480464 | CTD | |
| G | Cd80 | Cd80 molecule |
|
multiple interactions | ISO | 11 | 64,045,358 | 64,070,072 | RGD:6480464 | CTD | |
| G | Cd86 | CD86 molecule |
|
multiple interactions | ISO | 11 | 66,215,233 | 66,238,882 | RGD:6480464 | CTD | |
| G | Cd8a | CD8a molecule |
|
affects expression | EXP | 4 | 104,589,922 | 104,594,159 | RGD:6480464 | CTD | |
| G | Cdh2 | cadherin 2 |
|
affects expression | ISO | 18 | 8,048,920 | 8,267,974 | RGD:6480464 | CTD | |
| G | Cdh2 | cadherin 2 |
|
multiple interactions | ISO | 18 | 8,048,920 | 8,267,974 | RGD:6480464 | CTD | |
| G | Cdh2 | cadherin 2 |
|
affects expression | EXP | 18 | 8,048,920 | 8,267,974 | RGD:6480464 | CTD | |
| G | Cdh6 | cadherin 6 |
|
affects expression | EXP | 2 | 62,547,961 | 62,703,034 | RGD:6480464 | CTD | |
| G | Cdk5r1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
multiple interactions | ISO | 10 | 68,715,844 | 68,717,045 | RGD:6480464 | CTD | |
| G | Cdkn1a | cyclin-dependent kinase inhibitor 1A |
|
increases expression | ISO | 20 | 7,376,325 | 7,386,778 | RGD:6480464 | CTD | |
| G | Cdkn1b | cyclin-dependent kinase inhibitor 1B |
|
increases expression | ISO | 4 | 171,841,705 | 171,846,506 | RGD:6480464 | CTD | |
| G | Cdo1 | cysteine dioxygenase, type I |
|
multiple interactions | ISO | 18 | 40,914,028 | 40,928,671 | RGD:6480464 | CTD | |
| G | Cdon | cell adhesion associated, oncogene regulated |
|
affects expression | ISO | 8 | 35,238,899 | 35,291,743 | RGD:6480464 | CTD | |
| G | Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha |
|
decreases expression | ISO | 1 | 87,626,111 | 87,627,499 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
multiple interactions | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cebpb | CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression | ISO | 3 | 158,826,021 | 158,827,848 | RGD:6480464 | CTD | |
| G | Cenpa | centromere protein A |
|
decreases expression | ISO | 6 | 25,686,603 | 25,693,840 | RGD:6480464 | CTD | |
| G | Cers6 | ceramide synthase 6 |
|
multiple interactions | ISO | 3 | 50,979,559 | 51,252,510 | RGD:6480464 | CTD | |
| G | Cfd | complement factor D (adipsin) |
|
increases expression | EXP | 7 | 11,325,538 | 11,327,261 | RGD:6480464 | CTD | |
| G | Chrd | chordin |
|
affects expression | ISO | 11 | 82,401,701 | 82,410,401 | RGD:6480464 | CTD | |
| G | Cish | cytokine inducible SH2-containing protein |
|
multiple interactions | ISO | 8 | 112,541,034 | 112,545,982 | RGD:6480464 | CTD | |
| G | Ckb | creatine kinase, brain |
|
increases activity | ISO | 6 | 136,452,215 | 136,455,122 | RGD:6480464 | CTD | |
| G | Ckb | creatine kinase, brain |
|
multiple interactions | EXP | 6 | 136,452,215 | 136,455,122 | RGD:6480464 | CTD | |
| G | Clcn4 | chloride channel, voltage-sensitive 4 |
|
multiple interactions | ISO | X | 44,355,648 | 44,419,524 | RGD:6480464 | CTD | |
| G | Clcn6 | chloride channel, voltage-sensitive 6 |
|
increases expression | ISO | 5 | 165,079,773 | 165,110,594 | RGD:6480464 | CTD | |
| G | Clic4 | chloride intracellular channel 4 |
|
increases expression | ISO | 5 | 154,005,244 | 154,066,883 | RGD:6480464 | CTD | |
| G | Clstn1 | calsyntenin 1 |
|
decreases expression | ISO | 5 | 166,671,098 | 166,734,907 | RGD:6480464 | CTD | |
| G | Cltb | clathrin, light chain B |
|
affects expression | ISO | 17 | 16,063,715 | 16,081,277 | RGD:6480464 | CTD | |
| G | Clu | clusterin |
|
increases expression | ISO | 15 | 45,365,779 | 45,405,314 | RGD:6480464 | CTD | |
| G | Clu | clusterin |
|
increases expression | ISO | 15 | 45,365,779 | 45,405,314 | RGD:6480464 | CTD | |
| G | Col11a1 | collagen, type XI, alpha 1 |
|
affects expression | EXP | 2 | 209,996,467 | 210,193,379 | RGD:6480464 | CTD | |
| G | Col1a2 | collagen, type I, alpha 2 |
|
decreases expression | ISO | 4 | 29,393,645 | 29,428,572 | RGD:6480464 | CTD | |
| G | Col5a1 | collagen, type V, alpha 1 |
|
affects expression | EXP | 3 | 6,826,169 | 6,971,054 | RGD:6480464 | CTD | |
| G | Col5a2 | collagen, type V, alpha 2 |
|
affects expression | EXP | 9 | 44,374,113 | 44,525,086 | RGD:6480464 | CTD | |
| G | Copb2 | coatomer protein complex, subunit beta 2 (beta prime) | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cpb2 | carboxypeptidase B2 (plasma) |
|
decreases expression | ISO | 15 | 56,104,920 | 56,154,321 | RGD:6480464 | CTD | |
| G | Cpe | carboxypeptidase E | affects expression | EXP | RGD:6480464 | CTD | |||||
| G | Cpm | carboxypeptidase M |
|
increases expression | ISO | 7 | 56,931,920 | 56,992,248 | RGD:6480464 | CTD | |
| G | Crebbp | CREB binding protein |
|
multiple interactions | ISO | 10 | 11,598,680 | 11,724,122 | RGD:6480464 | CTD | |
| G | Crispld2 | cysteine-rich secretory protein LCCL domain containing 2 |
|
multiple interactions | ISO | 19 | 50,313,710 | 50,378,031 | RGD:6480464 | CTD | |
| G | Crybb2 | crystallin, beta B2 | affects expression | EXP | RGD:6480464 | CTD | |||||
| G | Csdc2 | cold shock domain containing C2, RNA binding |
|
multiple interactions | ISO | 7 | 120,290,137 | 120,323,640 | RGD:6480464 | CTD | |
| G | Csf2 | colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions | ISO | 10 | 39,665,850 | 39,667,831 | RGD:6480464 | CTD | |
| G | Csf3 | colony stimulating factor 3 (granulocyte) |
|
decreases expression | ISO | 10 | 87,473,990 | 87,476,365 | RGD:6480464 | CTD | |
| G | Ctsb | cathepsin B |
|
affects expression | EXP | 15 | 42,402,829 | 42,423,701 | RGD:6480464 | CTD | |
| G | Ctsh | cathepsin H |
|
increases expression | ISO | 8 | 94,971,689 | 94,990,434 | RGD:6480464 | CTD | |
| G | Ctsk | cathepsin K |
|
affects expression | ISO | 2 | 190,394,854 | 190,405,668 | RGD:6480464 | CTD | |
| G | Cuedc1 | CUE domain containing 1 |
|
multiple interactions | ISO | 10 | 76,467,673 | 76,488,136 | RGD:6480464 | CTD | |
| G | Cxadr | coxsackie virus and adenovirus receptor |
|
affects expression | ISO | 11 | 17,193,505 | 17,241,549 | RGD:6480464 | CTD | |
| G | Cxcl10 | chemokine (C-X-C motif) ligand 10 |
|
multiple interactions | ISO | 14 | 17,265,986 | 17,268,183 | RGD:6480464 | CTD | |
| G | Cxcl12 | chemokine (C-X-C motif) ligand 12 |
|
multiple interactions | ISO | 4 | 153,503,576 | 153,516,423 | RGD:6480464 | CTD | |
| G | Cxcl5 | chemokine (C-X-C motif) ligand 5 |
|
multiple interactions | ISO | 14 | 18,825,357 | 18,826,269 | RGD:6480464 | CTD | |
| G | Cxcr7 | chemokine (C-X-C motif) receptor 7 |
|
affects expression | ISO | 9 | 89,343,528 | 89,355,053 | RGD:6480464 | CTD | |
| G | Cxcr7 | chemokine (C-X-C motif) receptor 7 |
|
multiple interactions | ISO | 9 | 89,343,528 | 89,355,053 | RGD:6480464 | CTD | |
| G | Cylc2 | cylicin, basic protein of sperm head cytoskeleton 2 |
|
increases expression | ISO | 5 | 68,005,845 | 68,020,150 | RGD:6480464 | CTD | |
| G | Cyp19a1 | cytochrome P450, family 19, subfamily a, polypeptide 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp1a1 | cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions | EXP | 8 | 61,462,207 | 61,468,237 | RGD:6480464 | CTD | |
| G | Cyp24a1 | cytochrome P450, family 24, subfamily a, polypeptide 1 |
|
multiple interactions | ISO | 3 | 161,542,131 | 161,553,801 | RGD:6480464 | CTD | |
| G | Cyp26b1 | cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
multiple interactions | ISO | 4 | 118,734,786 | 118,751,606 | RGD:6480464 | CTD | |
| G | Cyp27a1 | cytochrome P450, family 27, subfamily a, polypeptide 1 |
|
affects expression | EXP | 9 | 74,039,204 | 74,068,648 | RGD:6480464 | CTD | |
| G | Cyp27b1 | cytochrome P450, family 27, subfamily b, polypeptide 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Cyp2a1 | cytochrome P450, family 2, subfamily a, polypeptide 1 |
|
affects expression | EXP | 1 | 82,006,828 | 82,020,282 | RGD:6480464 | CTD | |
| G | Cyp2c79 | cytochrome P450, family 2, subfamily c, polypeptide 79 |
|
decreases activity | ISO | 1 | 244,400,004 | 244,493,624 | RGD:6480464 | CTD | |
| G | Cyp3a2 | cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
decreases activity | ISO | 12 | 9,517,016 | 9,541,000 | RGD:6480464 | CTD | |
| G | Dact1 | dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) |
|
multiple interactions | ISO | 6 | 93,402,304 | 93,411,668 | RGD:6480464 | CTD | |
| G | Dag1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
increases expression | ISO | 8 | 113,470,871 | 113,483,433 | RGD:6480464 | CTD | |
| G | Daxx | death-domain associated protein |
|
affects expression | ISO | 20 | 5,121,854 | 5,127,601 | RGD:6480464 | CTD | |
| G | Dbp | D site of albumin promoter (albumin D-box) binding protein |
|
increases expression | EXP | 1 | 96,173,573 | 96,178,485 | RGD:6480464 | CTD | |
| G | Dcbld2 | discoidin, CUB and LCCL domain containing 2 |
|
multiple interactions | ISO | 11 | 42,941,795 | 42,980,245 | RGD:6480464 | CTD | |
| G | Ddit4 | DNA-damage-inducible transcript 4 |
|
affects expression | ISO | 20 | 27,252,273 | 27,254,371 | RGD:6480464 | CTD | |
| G | Ddx21 | DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
|
decreases expression | ISO | 20 | 29,838,671 | 29,860,514 | RGD:6480464 | CTD | |
| G | Ddx3y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 Y-linked |
|
decreases expression | ISO | X | 21,498,202 | 21,505,416 | RGD:6480464 | CTD | |
| G | Ddx50 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 |
|
affects expression | EXP | 20 | 29,867,955 | 29,897,253 | RGD:6480464 | CTD | |
| G | Dhcr24 | 24-dehydrocholesterol reductase |
|
decreases expression | ISO | 5 | 127,637,438 | 127,662,621 | RGD:6480464 | CTD | |
| G | Dhrs2 | dehydrogenase/reductase (SDR family) member 2 |
|
multiple interactions | ISO | 15 | 33,286,599 | 33,337,467 | RGD:6480464 | CTD | |
| G | Dhx9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 |
|
decreases expression | ISO | 13 | 68,471,256 | 68,507,999 | RGD:6480464 | CTD | |
| G | Dicer1 | dicer 1, ribonuclease type III |
|
decreases expression | ISO | 6 | 128,777,468 | 128,838,780 | RGD:6480464 | CTD | |
| G | Dkk2 | dickkopf 2 homolog (Xenopus laevis) |
|
decreases expression | ISO | 2 | 229,542,203 | 229,634,156 | RGD:6480464 | CTD | |
| G | Dleu2 | deleted in lymphocytic leukemia 2 |
|
decreases expression | ISO | 15 | 40,793,673 | 40,836,681 | RGD:6480464 | CTD | |
| G | Dmbt1 | deleted in malignant brain tumors 1 |
|
increases expression | ISO | 1 | 190,378,428 | 190,470,536 | RGD:6480464 | CTD | |
| G | Dmbt1 | deleted in malignant brain tumors 1 |
|
increases expression | EXP | 1 | 190,378,428 | 190,470,536 | RGD:6480464 | CTD | |
| G | Dnaja1 | DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
decreases expression | ISO | 5 | 58,100,794 | 58,111,705 | RGD:6480464 | CTD | |
| G | Dnajb1 | DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
increases expression | ISO | 19 | 26,213,739 | 26,217,480 | RGD:6480464 | CTD | |
| G | Dnajb4 | DnaJ (Hsp40) homolog, subfamily B, member 4 |
|
increases expression | ISO | 2 | 250,663,022 | 250,685,242 | RGD:6480464 | CTD | |
| G | Dnajb9 | DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression | ISO | 6 | 63,583,033 | 63,587,247 | RGD:6480464 | CTD | |
| G | Dnmbp | dynamin binding protein | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Dock9 | dedicator of cytokinesis 9 |
|
multiple interactions | ISO | 15 | 106,629,808 | 106,787,895 | RGD:6480464 | CTD | |
| G | Dram | damage-regulated autophagy modulator |
|
multiple interactions | ISO | 7 | 25,024,991 | 25,060,230 | RGD:6480464 | CTD | |
| G | Drd5 | dopamine receptor D5 |
|
increases expression | ISO | 14 | 77,768,060 | 77,769,487 | RGD:6480464 | CTD | |
| G | Dusp2 | dual specificity phosphatase 2 |
|
multiple interactions | ISO | 3 | 114,838,605 | 114,840,790 | RGD:6480464 | CTD | |
| G | Dusp2 | dual specificity phosphatase 2 |
|
decreases expression | ISO | 3 | 114,838,605 | 114,840,790 | RGD:6480464 | CTD | |
| G | Dusp4 | dual specificity phosphatase 4 |
|
decreases expression | ISO | 16 | 61,109,626 | 61,119,981 | RGD:6480464 | CTD | |
| G | Dusp5 | dual specificity phosphatase 5 |
|
multiple interactions | ISO | 1 | 259,754,234 | 259,767,645 | RGD:6480464 | CTD | |
| G | Dusp6 | dual specificity phosphatase 6 |
|
affects expression | EXP | 7 | 36,893,264 | 36,897,494 | RGD:6480464 | CTD | |
| G | Dync1li2 | dynein, cytoplasmic 1 light intermediate chain 2 |
|
affects expression | ISO | 19 | 469,163 | 510,647 | RGD:6480464 | CTD | |
| G | Eci1 | enoyl-CoA delta isomerase 1 |
|
affects expression | EXP | 10 | 13,683,000 | 13,697,179 | RGD:6480464 | CTD | |
| G | Edn3 | endothelin 3 |
|
multiple interactions | ISO | 3 | 166,491,368 | 166,514,051 | RGD:6480464 | CTD | |
| G | Edn3 | endothelin 3 |
|
affects expression | ISO | 3 | 166,491,368 | 166,514,051 | RGD:6480464 | CTD | |
| G | Ednra | endothelin receptor type A |
|
multiple interactions | ISO | 19 | 32,042,366 | 32,108,153 | RGD:6480464 | CTD | |
| G | Efemp1 | EGF-containing fibulin-like extracellular matrix protein 1 |
|
affects expression | ISO | 14 | 109,733,625 | 109,828,630 | RGD:6480464 | CTD | |
| G | Egfr | epidermal growth factor receptor |
|
multiple interactions | ISO | 14 | 97,617,358 | 97,788,211 | RGD:6480464 | CTD | |
| G | Egln3 | EGL nine homolog 3 (C. elegans) |
|
affects expression | EXP | 6 | 74,451,038 | 74,476,506 | RGD:6480464 | CTD | |
| G | Egr1 | early growth response 1 |
|
multiple interactions | ISO | 18 | 27,343,919 | 27,346,117 | RGD:6480464 | CTD | |
| G | Eif1 | eukaryotic translation initiation factor 1 |
|
multiple interactions | ISO | 10 | 89,255,637 | 89,257,728 | RGD:6480464 | CTD | |
| G | Eif1l1 | eukaryotic translation initiation factor 1-like 1 |
|
multiple interactions | ISO | 5 | 21,736,137 | 21,736,478 | RGD:6480464 | CTD | |
| G | Eif2s1 | eukaryotic translation initiation factor 2, subunit 1 alpha |
|
decreases expression | ISO | 6 | 101,495,444 | 101,520,113 | RGD:6480464 | CTD | |
| G | Eif5 | eukaryotic translation initiation factor 5 |
|
decreases expression | ISO | 6 | 136,311,381 | 136,318,586 | RGD:6480464 | CTD | |
| G | Eif5a | eukaryotic translation initiation factor 5A |
|
decreases expression | ISO | 10 | 56,760,289 | 56,764,689 | RGD:6480464 | CTD | |
| G | Elf3 | E74-like factor 3 |
|
multiple interactions | ISO | 13 | 48,258,893 | 48,263,713 | RGD:6480464 | CTD | |
| G | Elf3 | E74-like factor 3 |
|
increases expression | ISO | 13 | 48,258,893 | 48,263,713 | RGD:6480464 | CTD | |
| G | Ell | elongation factor RNA polymerase II |
|
increases expression | ISO | 16 | 19,349,939 | 19,397,253 | RGD:6480464 | CTD | |
| G | Elovl5 | ELOVL fatty acid elongase 5 |
|
decreases expression | ISO | 8 | 82,922,551 | 82,948,348 | RGD:6480464 | CTD | |
| G | Emp1 | epithelial membrane protein 1 |
|
multiple interactions | ISO | 4 | 172,315,122 | 172,335,536 | RGD:6480464 | CTD | |
| G | Enc1 | ectodermal-neural cortex 1 |
|
affects expression | ISO | 2 | 27,720,805 | 27,733,168 | RGD:6480464 | CTD | |
| G | Enc1 | ectodermal-neural cortex 1 |
|
multiple interactions | ISO | 2 | 27,720,805 | 27,733,168 | RGD:6480464 | CTD | |
| G | Endod1 | endonuclease domain containing 1 |
|
multiple interactions | ISO | 8 | 11,151,051 | 11,180,463 | RGD:6480464 | CTD | |
| G | Eng | endoglin | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Eno2 | enolase 2, gamma, neuronal |
|
affects expression | ISO | 4 | 160,891,003 | 160,897,723 | RGD:6480464 | CTD | |
| G | Enpp2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
affects expression | ISO | 7 | 91,295,824 | 91,377,850 | RGD:6480464 | CTD | |
| G | Enpp2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
multiple interactions | ISO | 7 | 91,295,824 | 91,377,850 | RGD:6480464 | CTD | |
| G | Entpd2 | ectonucleoside triphosphate diphosphohydrolase 2 |
|
increases expression | EXP | 3 | 3,564,380 | 3,569,801 | RGD:6480464 | CTD | |
| G | Epor | erythropoietin receptor |
|
affects expression | ISO | 8 | 21,061,310 | 21,065,886 | RGD:6480464 | CTD | |
| G | Erbb2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
decreases response to substance | ISO | 10 | 87,219,157 | 87,242,919 | RGD:6480464 | CTD | |
| G | Erbb3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
affects expression | ISO | 7 | 1,858,057 | 1,877,353 | RGD:6480464 | CTD | |
| G | Erbb4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
multiple interactions | ISO | 9 | 66,843,898 | 67,967,970 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
increases response to substance | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects response to substance | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects folding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
decreases activity | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
decreases expression | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
increases expression | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects expression | EXP | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | EXP | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects response to substance | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
decreases activity | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
decreases expression | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
decreases activity | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
multiple interactions | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr1 | estrogen receptor 1 |
|
affects binding | ISO | 1 | 35,523,680 | 35,759,891 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
increases activity | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
decreases activity | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
affects expression | EXP | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
increases response to substance | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Esr2 | estrogen receptor 2 (ER beta) |
|
multiple interactions | ISO | 6 | 98,691,167 | 98,775,299 | RGD:6480464 | CTD | |
| G | Evi2a | ecotropic viral integration site 2A |
|
multiple interactions | ISO | 10 | 65,713,406 | 65,717,306 | RGD:6480464 | CTD | |
| G | F11 | coagulation factor XI |
|
increases activity | ISO | 16 | 50,276,330 | 50,298,903 | RGD:6480464 | CTD | |
| G | F12 | coagulation factor XII (Hageman factor) |
|
increases activity | ISO | 17 | 15,251,611 | 15,259,583 | RGD:6480464 | CTD | |
| G | F13a1 | coagulation factor XIII, A1 polypeptide |
|
affects expression | ISO | 17 | 34,093,525 | 34,270,498 | RGD:6480464 | CTD | |
| G | F2r | coagulation factor II (thrombin) receptor |
|
increases expression | ISO | 2 | 25,985,800 | 25,989,072 | RGD:6480464 | CTD | |
| G | F8 | coagulation factor VIII, procoagulant component |
|
increases activity | ISO | 18 | 121,134 | 162,008 | RGD:6480464 | CTD | |
| G | F8 | coagulation factor VIII, procoagulant component |
|
increases expression | ISO | 18 | 121,134 | 162,008 | RGD:6480464 | CTD | |
| G | Fabp4 | fatty acid binding protein 4, adipocyte |
|
increases expression | ISO | 2 | 93,536,133 | 93,540,734 | RGD:6480464 | CTD | |
| G | Fadd | Fas (TNFRSF6)-associated via death domain |
|
multiple interactions | ISO | 1 | 205,010,363 | 205,012,768 | RGD:6480464 | CTD | |
| G | Fam134b | family with sequence similarity 134, member B |
|
multiple interactions | ISO | 2 | 77,470,558 | 77,566,123 | RGD:6480464 | CTD | |
| G | Fam65b | family with sequence similarity 65, member B |
|
multiple interactions | ISO | 17 | 47,394,370 | 47,492,203 | RGD:6480464 | CTD | |
| G | Fap | fibroblast activation protein, alpha |
|
affects expression | ISO | 3 | 44,457,151 | 44,525,602 | RGD:6480464 | CTD | |
| G | Fgd6 | FYVE, RhoGEF and PH domain containing 6 |
|
multiple interactions | ISO | 7 | 31,160,021 | 31,286,379 | RGD:6480464 | CTD | |
| G | Fgf9 | fibroblast growth factor 9 |
|
affects expression | EXP | 15 | 37,115,068 | 37,155,652 | RGD:6480464 | CTD | |
| G | Fgfr2 | fibroblast growth factor receptor 2 |
|
multiple interactions | ISO | 1 | 189,482,975 | 189,589,279 | RGD:6480464 | CTD | |
| G | Fhl2 | four and a half LIM domains 2 |
|
multiple interactions | ISO | 9 | 42,319,997 | 42,349,055 | RGD:6480464 | CTD | |
| G | Fhl2 | four and a half LIM domains 2 |
|
affects expression | ISO | 9 | 42,319,997 | 42,349,055 | RGD:6480464 | CTD | |
| G | Fis1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) |
|
increases expression | EXP | 12 | 20,806,840 | 20,821,766 | RGD:6480464 | CTD | |
| G | Fis1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) |
|
affects expression | EXP | 12 | 20,806,840 | 20,821,766 | RGD:6480464 | CTD | |
| G | Fkbp3 | FK506 binding protein 3 |
|
affects expression | EXP | 6 | 86,410,859 | 86,422,588 | RGD:6480464 | CTD | |
| G | Flnb | filamin B, beta |
|
multiple interactions | ISO | 15 | 18,949,027 | 19,082,504 | RGD:6480464 | CTD | |
| G | Flnb | filamin B, beta |
|
affects expression | ISO | 15 | 18,949,027 | 19,082,504 | RGD:6480464 | CTD | |
| G | Flnb | filamin B, beta |
|
multiple interactions | ISO | 15 | 18,949,027 | 19,082,504 | RGD:6480464 | CTD | |
| G | Flnc | filamin C, gamma |
|
decreases expression | ISO | 4 | 56,313,707 | 56,341,400 | RGD:6480464 | CTD | |
| G | Flrt1 | fibronectin leucine rich transmembrane protein 1 |
|
affects expression | ISO | 1 | 209,764,672 | 209,770,132 | RGD:6480464 | CTD | |
| G | Fmnl1 | formin-like 1 |
|
affects expression | ISO | 10 | 92,343,548 | 92,384,092 | RGD:6480464 | CTD | |
| G | Fn1 | fibronectin 1 |
|
multiple interactions | ISO | 9 | 70,702,181 | 70,771,155 | RGD:6480464 | CTD | |
| G | Fosl2 | fos-like antigen 2 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Foxe1 | forkhead box E1 (thyroid transcription factor 2) |
|
affects expression | EXP | 5 | 62,905,210 | 62,908,018 | RGD:6480464 | CTD | |
| G | Foxo1 | forkhead box O1 |
|
affects expression | ISO | 2 | 141,127,345 | 141,203,446 | RGD:6480464 | CTD | |
| G | Foxo1 | forkhead box O1 |
|
multiple interactions | ISO | 2 | 141,127,345 | 141,203,446 | RGD:6480464 | CTD | |
| G | Fst | follistatin |
|
affects expression | ISO | 2 | 46,542,246 | 46,550,678 | RGD:6480464 | CTD | |
| G | Fst | follistatin |
|
multiple interactions | ISO | 2 | 46,542,246 | 46,550,678 | RGD:6480464 | CTD | |
| G | Fut9 | fucosyltransferase 9 (alpha (1,3) fucosyltransferase) |
|
multiple interactions | ISO | 5 | 40,716,822 | 40,934,545 | RGD:6480464 | CTD | |
| G | Fyttd1 | forty-two-three domain containing 1 |
|
decreases expression | ISO | 11 | 69,700,526 | 69,720,622 | RGD:6480464 | CTD | |
| G | Fzd6 | frizzled family receptor 6 |
|
affects expression | ISO | 7 | 74,562,307 | 74,594,014 | RGD:6480464 | CTD | |
| G | G0s2 | G0/G1switch 2 |
|
multiple interactions | ISO | 13 | 109,121,297 | 109,122,209 | RGD:6480464 | CTD | |
| G | Gabarap | GABA(A) receptor-associated protein |
|
affects expression | EXP | 10 | 56,837,772 | 56,840,707 | RGD:6480464 | CTD | |
| G | Gabbr2 | gamma-aminobutyric acid (GABA) B receptor 2 |
|
multiple interactions | ISO | 5 | 63,241,397 | 63,611,907 | RGD:6480464 | CTD | |
| G | Gabpa | GA binding protein transcription factor, alpha subunit |
|
increases expression | ISO | 11 | 24,323,963 | 24,352,754 | RGD:6480464 | CTD | |
| G | Gabrg1 | gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
|
affects expression | EXP | 14 | 39,878,182 | 39,951,391 | RGD:6480464 | CTD | |
| G | Gabrr1 | gamma-aminobutyric acid (GABA) A receptor, rho 1 |
|
multiple interactions | ISO | 5 | 49,421,463 | 49,458,535 | RGD:6480464 | CTD | |
| G | Gabrr1 | gamma-aminobutyric acid (GABA) A receptor, rho 1 |
|
affects expression | ISO | 5 | 49,421,463 | 49,458,535 | RGD:6480464 | CTD | |
| G | Gad1 | glutamate decarboxylase 1 |
|
multiple interactions | ISO | 3 | 52,789,370 | 52,830,038 | RGD:6480464 | CTD | |
| G | Gal | galanin/GMAP prepropeptide |
|
decreases expression | ISO | 1 | 205,936,352 | 205,941,215 | RGD:6480464 | CTD | |
| G | Gas6 | growth arrest specific 6 |
|
multiple interactions | ISO | 16 | 80,900,159 | 80,930,929 | RGD:6480464 | CTD | |
| G | Gas6 | growth arrest specific 6 |
|
increases expression | ISO | 16 | 80,900,159 | 80,930,929 | RGD:6480464 | CTD | |
| G | Gas6 | growth arrest specific 6 |
|
affects expression | EXP | 16 | 80,900,159 | 80,930,929 | RGD:6480464 | CTD | |
| G | Gata2 | GATA binding protein 2 |
|
increases expression | ISO | 4 | 122,279,753 | 122,288,528 | RGD:6480464 | CTD | |
| G | Gcnt1 | glucosaminyl (N-acetyl) transferase 1, core 2 |
|
affects expression | ISO | 1 | 220,824,976 | 220,829,980 | RGD:6480464 | CTD | |
| G | Gfra2 | GDNF family receptor alpha 2 |
|
increases expression | EXP | 15 | 51,279,770 | 51,371,053 | RGD:6480464 | CTD | |
| G | Gh1 | growth hormone 1 |
|
multiple interactions | ISO | 10 | 95,692,240 | 95,694,117 | RGD:6480464 | CTD | |
| G | Ghr | growth hormone receptor |
|
decreases expression | ISO | 2 | 52,496,517 | 52,658,066 | RGD:6480464 | CTD | |
| G | Ghrh | growth hormone releasing hormone |
|
affects expression | EXP | 3 | 148,027,235 | 148,046,352 | RGD:6480464 | CTD | |
| G | Ghrhr | growth hormone releasing hormone receptor |
|
affects expression | EXP | 4 | 84,135,530 | 84,148,503 | RGD:6480464 | CTD | |
| G | Gjb2 | gap junction protein, beta 2 |
|
increases expression | ISO | 15 | 36,153,526 | 36,159,490 | RGD:6480464 | CTD | |
| G | Glrb | glycine receptor, beta |
|
affects expression | ISO | 2 | 172,451,807 | 172,522,841 | RGD:6480464 | CTD | |
| G | Glrx | glutaredoxin (thioltransferase) |
|
affects expression | ISO | 2 | 2,888,605 | 2,899,216 | RGD:6480464 | CTD | |
| G | Glul | glutamate-ammonia ligase | affects expression | EXP | RGD:6480464 | CTD | |||||
| G | Glyat | glycine-N-acyltransferase |
|
affects expression | ISO | 1 | 215,653,254 | 215,666,991 | RGD:6480464 | CTD | |
| G | Gnb1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
affects expression | EXP | 5 | 172,341,135 | 172,386,772 | RGD:6480464 | CTD | |
| G | Gnb4 | guanine nucleotide binding protein (G protein), beta polypeptide 4 |
|
increases expression | ISO | 2 | 118,791,192 | 118,827,413 | RGD:6480464 | CTD | |
| G | Gnrh1 | gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
multiple interactions | ISO | 15 | 47,303,309 | 47,307,517 | RGD:6480464 | CTD | |
| G | Golga5 | golgin A5 |
|
decreases expression | ISO | 6 | 126,740,320 | 126,765,513 | RGD:6480464 | CTD | |
| G | Gpc1 | glypican 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Gpc3 | glypican 3 |
|
increases expression | EXP | X | 139,192,115 | 139,560,649 | RGD:6480464 | CTD | |
| G | Gpnmb | glycoprotein (transmembrane) nmb |
|
multiple interactions | ISO | 4 | 77,161,352 | 77,182,624 | RGD:6480464 | CTD | |
| G | Gpr125 | G protein-coupled receptor 125 |
|
increases expression | ISO | 14 | 65,770,256 | 65,778,671 | RGD:6480464 | CTD | |
| G | Gpr56 | G protein-coupled receptor 56 |
|
affects expression | ISO | 19 | 10,438,332 | 10,475,607 | RGD:6480464 | CTD | |
| G | Gprc5c | G protein-coupled receptor, family C, group 5, member C |
|
multiple interactions | ISO | 10 | 104,731,909 | 104,754,468 | RGD:6480464 | CTD | |
| G | Grb10 | growth factor receptor bound protein 10 |
|
affects expression | ISO | 14 | 92,814,797 | 92,911,442 | RGD:6480464 | CTD | |
| G | Grb10 | growth factor receptor bound protein 10 |
|
multiple interactions | ISO | 14 | 92,814,797 | 92,911,442 | RGD:6480464 | CTD | |
| G | Grhl1 | grainyhead-like 1 (Drosophila) |
|
decreases expression | ISO | 6 | 42,217,279 | 42,260,621 | RGD:6480464 | CTD | |
| G | Grina | glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) |
|
affects expression | EXP | 7 | 114,277,208 | 114,280,339 | RGD:6480464 | CTD | |
| G | Grk5 | G protein-coupled receptor kinase 5 |
|
affects expression | ISO | 1 | 267,495,534 | 267,693,144 | RGD:6480464 | CTD | |
| G | Grk5 | G protein-coupled receptor kinase 5 |
|
multiple interactions | ISO | 1 | 267,495,534 | 267,693,144 | RGD:6480464 | CTD | |
| G | Gyg1 | glycogenin 1 |
|
multiple interactions | ISO | 2 | 105,264,657 | 105,307,070 | RGD:6480464 | CTD | |
| G | H2afy | H2A histone family, member Y |
|
affects expression | EXP | 17 | 14,457,307 | 14,520,963 | RGD:6480464 | CTD | |
| G | Hal | histidine ammonia lyase |
|
affects expression | EXP | 7 | 30,520,913 | 30,551,145 | RGD:6480464 | CTD | |
| G | Hapln1 | hyaluronan and proteoglycan link protein 1 |
|
affects expression | ISO | 2 | 19,576,064 | 19,638,106 | RGD:6480464 | CTD | |
| G | Has2 | hyaluronan synthase 2 |
|
multiple interactions | ISO | 7 | 93,230,135 | 93,256,139 | RGD:6480464 | CTD | |
| G | Hba2 | hemoglobin, alpha 2 |
|
affects expression | EXP | 10 | 15,570,930 | 15,571,773 | RGD:6480464 | CTD | |
| G | Hbegf | heparin-binding EGF-like growth factor |
|
multiple interactions | ISO | 18 | 29,143,567 | 29,153,944 | RGD:6480464 | CTD | |
| G | Hbg1 | hemoglobin, gamma A |
|
affects expression | EXP | 1 | 161,640,359 | 161,641,737 | RGD:6480464 | CTD | |
| G | Hbp1 | HMG-box transcription factor 1 |
|
increases expression | ISO | 6 | 50,201,281 | 50,227,095 | RGD:6480464 | CTD | |
| G | Heg1 | heart development protein with EGF-like domains 1 |
|
multiple interactions | ISO | 11 11 |
68,828,748 68,828,748 |
68,889,177 68,912,073 |
RGD:6480464 | CTD | |
| G | Heg1 | heart development protein with EGF-like domains 1 |
|
affects expression | ISO | 11 11 |
68,828,748 68,828,748 |
68,889,177 68,912,073 |
RGD:6480464 | CTD | |
| G | Herpud1 | homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
increases expression | ISO | 19 | 11,036,567 | 11,046,914 | RGD:6480464 | CTD | |
| G | Hey2 | hairy/enhancer-of-split related with YRPW motif 2 |
|
multiple interactions | ISO | 1 | 27,505,117 | 27,515,204 | RGD:6480464 | CTD | |
| G | Hgf | hepatocyte growth factor |
|
decreases expression | ISO | 4 | 14,864,357 | 14,932,513 | RGD:6480464 | CTD | |
| G | Hist1h2af | histone cluster 1, H2af |
|
affects expression | ISO | 17 | 48,513,674 | 48,514,066 | RGD:6480464 | CTD | |
| G | Hk1 | hexokinase 1 | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Hmcn1 | hemicentin 1 |
|
multiple interactions | ISO | 13 | 65,296,682 | 65,779,372 | RGD:6480464 | CTD | |
| G | Hmga2 | high mobility group AT-hook 2 |
|
affects expression | ISO | 7 | 59,638,555 | 59,753,791 | RGD:6480464 | CTD | |
| G | Hmgb1 | high mobility group box 1 | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Hmgb1 | high mobility group box 1 | affects expression | EXP | RGD:6480464 | CTD | |||||
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
decreases expression | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
affects expression | EXP | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
multiple interactions | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hmox1 | heme oxygenase (decycling) 1 |
|
increases expression | ISO | 19 | 13,963,139 | 13,969,960 | RGD:6480464 | CTD | |
| G | Hnrnpa2b1 | heterogeneous nuclear ribonucleoprotein A2/B1 |
|
decreases expression | ISO | 4 | 79,700,327 | 79,704,116 | RGD:6480464 | CTD | |
| G | Hnrnpu | heterogeneous nuclear ribonucleoprotein U |
|
decreases expression | ISO | 13 | 93,978,865 | 93,987,654 | RGD:6480464 | CTD | |
| G | Homer2 | homer homolog 2 (Drosophila) |
|
affects expression | ISO | 1 | 137,827,128 | 137,933,089 | RGD:6480464 | CTD | |
| G | Hoxa1 | homeo box A1 |
|
affects expression | EXP | 4 | 80,456,728 | 80,458,388 | RGD:6480464 | CTD | |
| G | Hpcal1 | hippocalcin-like 1 |
|
multiple interactions | ISO | 6 | 41,458,062 | 41,576,771 | RGD:6480464 | CTD | |
| G | Hsd17b4 | hydroxysteroid (17-beta) dehydrogenase 4 |
|
affects expression | EXP | 18 | 45,157,435 | 45,251,606 | RGD:6480464 | CTD | |
| G | Hsp90ab1 | heat shock protein 90 alpha (cytosolic), class B member 1 |
|
decreases expression | ISO | 9 | 11,033,496 | 11,038,868 | RGD:6480464 | CTD | |
| G | Hsp90b1 | heat shock protein 90, beta, member 1 |
|
decreases expression | ISO | 7 | 23,332,986 | 23,347,525 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
affects expression | ISO | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1a | heat shock protein 1A |
|
increases expression | EXP | 20 | 3,945,716 | 3,959,552 | RGD:6480464 | CTD | |
| G | Hspa1b | heat shock protein 1B |
|
multiple interactions | ISO | 20 | 3,955,274 | 3,957,748 | RGD:6480464 | CTD | |
| G | Hspa1b | heat shock protein 1B |
|
affects expression | ISO | 20 | 3,955,274 | 3,957,748 | RGD:6480464 | CTD | |
| G | Hspa4 | heat shock protein 4 |
|
decreases expression | ISO | 10 | 38,705,629 | 38,749,058 | RGD:6480464 | CTD | |
| G | Hspa8 | heat shock 70kDa protein 8 |
|
decreases expression | ISO | 8 | 43,784,035 | 43,787,760 | RGD:6480464 | CTD | |
| G | Hspb8 | heat shock protein B8 |
|
multiple interactions | ISO | 12 | 41,407,166 | 41,421,565 | RGD:6480464 | CTD | |
| G | Hspd1 | heat shock protein 1 (chaperonin) |
|
decreases expression | ISO | 9 | 53,884,193 | 53,895,043 | RGD:6480464 | CTD | |
| G | Hspd1 | heat shock protein 1 (chaperonin) |
|
affects expression | EXP | 9 | 53,884,193 | 53,895,043 | RGD:6480464 | CTD | |
| G | Htr2a | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
multiple interactions | EXP | 15 | 55,463,743 | 55,532,293 | RGD:6480464 | CTD | |
| G | Htr2a | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
affects expression | ISO | 15 | 55,463,743 | 55,532,293 | RGD:6480464 | CTD | |
| G | Htr3a | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
|
multiple interactions | ISO | 8 | 52,161,147 | 52,173,514 | RGD:6480464 | CTD | |
| G | Htr5a | 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
|
affects expression | EXP | 4 | 2,707,261 | 2,716,944 | RGD:6480464 | CTD | |
| G | Id1 | inhibitor of DNA binding 1 |
|
affects expression | ISO | 3 | 143,086,162 | 143,087,289 | RGD:6480464 | CTD | |
| G | Id4 | inhibitor of DNA binding 4 |
|
multiple interactions | ISO | 17 | 22,525,292 | 22,527,861 | RGD:6480464 | CTD | |
| G | Idh2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
multiple interactions | ISO | 1 | 135,876,052 | 135,895,373 | RGD:6480464 | CTD | |
| G | Idh2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
affects expression | ISO | 1 | 135,876,052 | 135,895,373 | RGD:6480464 | CTD | |
| G | Idh2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
multiple interactions | ISO | 1 | 135,876,052 | 135,895,373 | RGD:6480464 | CTD | |
| G | Idh2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
affects expression | EXP | 1 | 135,876,052 | 135,895,373 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
affects expression | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ier3 | immediate early response 3 |
|
multiple interactions | ISO | 20 | 3,076,568 | 3,077,772 | RGD:6480464 | CTD | |
| G | Ifit2 | interferon-induced protein with tetratricopeptide repeats 2 |
|
affects expression | ISO | 1 | 238,559,729 | 238,565,793 | RGD:6480464 | CTD | |
| G | Ifngr2 | interferon gamma receptor 2 |
|
multiple interactions | ISO | 11 | 31,508,721 | 31,526,993 | RGD:6480464 | CTD | |
| G | Ifrd1 | interferon-related developmental regulator 1 | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Igf1 | insulin-like growth factor 1 |
|
multiple interactions | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
decreases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
decreases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
affects expression | EXP | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
increases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
decreases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
decreases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
increases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
decreases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf1 | insulin-like growth factor 1 |
|
decreases expression | ISO | 7 | 24,531,669 | 24,605,742 | RGD:6480464 | CTD | |
| G | Igf2 | insulin-like growth factor 2 |
|
increases expression | EXP | 1 | 202,906,624 | 202,915,231 | RGD:6480464 | CTD | |
| G | Igfbp3 | insulin-like growth factor binding protein 3 |
|
increases expression | ISO | 14 | 87,959,153 | 87,967,085 | RGD:6480464 | CTD | |
| G | Igfbp3 | insulin-like growth factor binding protein 3 |
|
increases expression | ISO | 14 | 87,959,153 | 87,967,085 | RGD:6480464 | CTD | |
| G | Igfbp4 | insulin-like growth factor binding protein 4 |
|
affects expression | ISO | 10 | 87,822,429 | 87,834,315 | RGD:6480464 | CTD | |
| G | Igfbp6 | insulin-like growth factor binding protein 6 |
|
increases expression | EXP | 7 | 140,885,388 | 140,890,028 | RGD:6480464 | CTD | |
| G | Il10ra | interleukin 10 receptor, alpha |
|
increases expression | ISO | 8 | 48,211,040 | 48,224,439 | RGD:6480464 | CTD | |
| G | Il12a | interleukin 12A |
|
decreases expression | ISO | 2 | 158,710,261 | 158,717,689 | RGD:6480464 | CTD | |
| G | Il1b | interleukin 1 beta |
|
multiple interactions | ISO | 3 | 116,964,422 | 116,970,867 | RGD:6480464 | CTD | |
| G | Il1rap | interleukin 1 receptor accessory protein |
|
affects expression | ISO | 11 | 76,092,252 | 76,222,576 | RGD:6480464 | CTD | |
| G | Il4r | interleukin 4 receptor |
|
affects expression | ISO | 1 | 184,612,903 | 184,637,863 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
decreases expression | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
decreases expression | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
multiple interactions | EXP | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il6 | interleukin 6 |
|
decreases expression | ISO | 4 | 456,799 | 461,376 | RGD:6480464 | CTD | |
| G | Il7r | interleukin 7 receptor |
|
affects expression | ISO | 2 | 59,103,992 | 59,128,004 | RGD:6480464 | CTD | |
| G | Inhba | inhibin beta-A |
|
multiple interactions | ISO | 17 | 57,244,466 | 57,257,531 | RGD:6480464 | CTD | |
| G | Inpp4b | inositol polyphosphate-4-phosphatase, type II |
|
affects expression | ISO | 19 | 27,722,430 | 28,363,639 | RGD:6480464 | CTD | |
| G | Inpp5a | inositol polyphosphate-5-phosphatase A |
|
multiple interactions | ISO | 1 | 199,187,936 | 199,395,997 | RGD:6480464 | CTD | |
| G | Insig1 | insulin induced gene 1 |
|
increases expression | ISO | 4 | 2,577,468 | 2,585,682 | RGD:6480464 | CTD | |
| G | Iqgap1 | IQ motif containing GTPase activating protein 1 |
|
decreases expression | ISO | 1 | 136,552,358 | 136,642,545 | RGD:6480464 | CTD | |
| G | Irf7 | interferon regulatory factor 7 |
|
affects expression | EXP | 1 | 201,456,689 | 201,459,756 | RGD:6480464 | CTD | |
| G | Isg20 | interferon stimulated exonuclease gene 20 |
|
affects expression | ISO | 1 | 134,631,524 | 134,637,868 | RGD:6480464 | CTD | |
| G | Isg20 | interferon stimulated exonuclease gene 20 |
|
multiple interactions | ISO | 1 | 134,631,524 | 134,637,868 | RGD:6480464 | CTD | |
| G | Itgb1 | integrin, beta 1 |
|
increases expression | ISO | 19 | 58,600,095 | 58,647,531 | RGD:6480464 | CTD | |
| G | Itgb1 | integrin, beta 1 |
|
increases expression | ISO | 19 | 58,600,095 | 58,647,531 | RGD:6480464 | CTD | |
| G | Itpr3 | inositol 1,4,5-trisphosphate receptor, type 3 |
|
affects expression | ISO | 20 | 5,292,430 | 5,357,502 | RGD:6480464 | CTD | |
| G | Ivl | involucrin |
|
affects expression | ISO | 2 | 185,556,271 | 185,558,310 | RGD:6480464 | CTD | |
| G | Ivl | involucrin |
|
multiple interactions | ISO | 2 | 185,556,271 | 185,558,310 | RGD:6480464 | CTD | |
| G | Jag1 | jagged 1 |
|
multiple interactions | ISO | 3 | 125,181,063 | 125,216,481 | RGD:6480464 | CTD | |
| G | Jak2 | Janus kinase 2 |
|
multiple interactions | ISO | 1 | 232,915,995 | 232,974,763 | RGD:6480464 | CTD | |
| G | Jun | jun proto-oncogene |
|
increases expression | ISO | 5 | 115,358,166 | 115,361,259 | RGD:6480464 | CTD | |
| G | Kazn | kazrin, periplakin interacting protein |
|
multiple interactions | ISO | 5 | 161,041,203 | 161,399,651 | RGD:6480464 | CTD | |
| G | Kcne1 | potassium voltage-gated channel, Isk-related family, member 1 |
|
increases expression | EXP | 11 | 32,344,529 | 32,355,189 | RGD:6480464 | CTD | |
| G | Kcnh5 | potassium voltage-gated channel, subfamily H (eag-related), member 5 |
|
affects expression | EXP | 6 | 97,484,188 | 97,772,082 | RGD:6480464 | CTD | |
| G | Kcnn4 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
affects expression | ISO | 1 | 79,613,736 | 79,628,887 | RGD:6480464 | CTD | |
| G | Kcnn4 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
multiple interactions | ISO | 1 | 79,613,736 | 79,628,887 | RGD:6480464 | CTD | |
| G | Kctd12 | potassium channel tetramerisation domain containing 12 |
|
affects expression | ISO | 15 | 86,986,827 | 86,987,810 | RGD:6480464 | CTD | |
| G | Kctd12 | potassium channel tetramerisation domain containing 12 |
|
multiple interactions | ISO | 15 | 86,986,827 | 86,987,810 | RGD:6480464 | CTD | |
| G | Kif20a | kinesin family member 20A |
|
decreases expression | ISO | 18 | 27,100,044 | 27,108,530 | RGD:6480464 | CTD | |
| G | Kif3c | kinesin family member 3C |
|
multiple interactions | ISO | 6 | 26,342,388 | 26,381,233 | RGD:6480464 | CTD | |
| G | Klf10 | Kruppel-like factor 10 |
|
affects expression | ISO | 7 | 73,821,190 | 73,826,866 | RGD:6480464 | CTD | |
| G | Klf6 | Kruppel-like factor 6 |
|
decreases expression | EXP | 17 | 75,578,498 | 75,585,072 | RGD:6480464 | CTD | |
| G | Klhl24 | kelch-like family member 24 |
|
increases expression | ISO | 11 | 83,094,560 | 83,126,617 | RGD:6480464 | CTD | |
| G | Klrc1 | killer cell lectin-like receptor subfamily C, member 1 |
|
increases expression | ISO | 4 | 166,976,056 | 166,986,568 | RGD:6480464 | CTD | |
| G | Klrc2 | killer cell lectin-like receptor subfamily C, member 2 |
|
multiple interactions | ISO | 4 | 166,956,614 | 166,967,757 | RGD:6480464 | CTD | |
| G | Klrc2 | killer cell lectin-like receptor subfamily C, member 2 |
|
affects expression | ISO | 4 | 166,956,614 | 166,967,757 | RGD:6480464 | CTD | |
| G | Klrc2 | killer cell lectin-like receptor subfamily C, member 2 |
|
multiple interactions | ISO | 4 | 166,956,614 | 166,967,757 | RGD:6480464 | CTD | |
| G | Klrk1 | killer cell lectin-like receptor subfamily K, member 1 |
|
multiple interactions | ISO | 4 | 166,914,786 | 166,922,659 | RGD:6480464 | CTD | |
| G | Kpna2 | karyopherin alpha 2 |
|
decreases expression | ISO | 10 | 96,342,214 | 96,352,613 | RGD:6480464 | CTD | |
| G | Kpnb1 | karyopherin (importin) beta 1 |
|
decreases expression | ISO | 10 | 85,882,382 | 85,910,805 | RGD:6480464 | CTD | |
| G | Krt17 | keratin 17 |
|
multiple interactions | ISO | 10 | 89,185,097 | 89,189,816 | RGD:6480464 | CTD | |
| G | Krt34 | keratin 34 |
|
multiple interactions | ISO | 10 | 88,973,452 | 88,977,141 | RGD:6480464 | CTD | |
| G | L3mbtl1 | l(3)mbt-like 1 (Drosophila) |
|
decreases expression | ISO | 3 | 153,811,334 | 153,836,990 | RGD:6480464 | CTD | |
| G | Lamc1 | laminin, gamma 1 |
|
affects expression | ISO | 13 | 68,241,453 | 68,369,419 | RGD:6480464 | CTD | |
| G | Lbh | limb bud and heart development |
|
multiple interactions | ISO | 6 | 22,662,376 | 22,664,667 | RGD:6480464 | CTD | |
| G | Lcn2 | lipocalin 2 |
|
affects expression | ISO | 3 | 11,511,402 | 11,514,747 | RGD:6480464 | CTD | |
| G | Ldlr | low density lipoprotein receptor |
|
increases expression | ISO | 8 | 20,824,040 | 20,846,920 | RGD:6480464 | CTD | |
| G | Ldlrad4 | low density lipoprotein receptor class A domain containing 4 |
|
multiple interactions | ISO | 18 | 64,755,404 | 64,788,816 | RGD:6480464 | CTD | |
| G | Lhb | luteinizing hormone beta |
|
multiple interactions | EXP | 1 | 95,892,999 | 95,893,988 | RGD:6480464 | CTD | |
| G | Limch1 | LIM and calponin homology domains 1 |
|
multiple interactions | ISO | 14 | 43,722,254 | 44,049,555 | RGD:6480464 | CTD | |
| G | Liph | lipase, member H | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Lmcd1 | LIM and cysteine-rich domains 1 |
|
multiple interactions | ISO | 4 | 148,071,431 | 148,130,313 | RGD:6480464 | CTD | |
| G | Lmnb2 | lamin B2 |
|
multiple interactions | ISO | 7 | 10,303,626 | 10,326,068 | RGD:6480464 | CTD | |
| G | Lmnb2 | lamin B2 |
|
affects expression | ISO | 7 | 10,303,626 | 10,326,068 | RGD:6480464 | CTD | |
| G | LOC100359600 | karyopherin alpha 2-like |
|
decreases expression | ISO | 6 | 10,523,393 | 10,524,982 | RGD:6480464 | CTD | |
| G | LOC100360205 | palladin |
|
affects expression | ISO | 16 | 31,854,459 | 31,933,792 | RGD:6480464 | CTD | |
| G | LOC100360260 | chromobox homolog 3-like |
|
decreases expression | ISO | 16 | 32,507,709 | 32,508,260 | RGD:6480464 | CTD | |
| G | LOC294154 | similar to chromosome 6 open reading frame 106 isoform a |
|
decreases expression | ISO | 20 | 5,965,992 | 6,033,724 | RGD:6480464 | CTD | |
| G | LOC500300 | similar to hypothetical protein MGC6835 |
|
decreases expression | ISO | 4 | 153,000,782 | 153,002,562 | RGD:6480464 | CTD | |
| G | Lox | lysyl oxidase |
|
affects expression | EXP | 18 | 47,896,674 | 47,970,829 | RGD:6480464 | CTD | |
| G | Lpl | lipoprotein lipase |
|
multiple interactions | ISO | 16 | 22,533,105 | 22,556,905 | RGD:6480464 | CTD | |
| G | Lpl | lipoprotein lipase |
|
increases expression | ISO | 16 | 22,533,105 | 22,556,905 | RGD:6480464 | CTD | |
| G | Lrig1 | leucine-rich repeats and immunoglobulin-like domains 1 |
|
affects expression | ISO | 4 | 128,919,630 | 129,082,488 | RGD:6480464 | CTD | |
| G | Lrig1 | leucine-rich repeats and immunoglobulin-like domains 1 |
|
multiple interactions | ISO | 4 | 128,919,630 | 129,082,488 | RGD:6480464 | CTD | |
| G | Lrrc20 | leucine rich repeat containing 20 |
|
multiple interactions | ISO | 20 | 28,889,911 | 28,951,225 | RGD:6480464 | CTD | |
| G | Ltb | lymphotoxin beta (TNF superfamily, member 3) |
|
decreases expression | ISO | 20 | 3,666,524 | 3,668,369 | RGD:6480464 | CTD | |
| G | Ltbp1 | latent transforming growth factor beta binding protein 1 |
|
affects expression | ISO | 6 | 19,942,626 | 20,355,084 | RGD:6480464 | CTD | |
| G | Lum | lumican |
|
affects expression | ISO | 7 | 35,083,480 | 35,090,284 | RGD:6480464 | CTD | |
| G | Ly6i | lymphocyte antigen 6 complex, locus I |
|
affects expression | EXP | 7 | 113,306,011 | 113,310,996 | RGD:6480464 | CTD | |
| G | Lyn | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
multiple interactions | ISO | 5 | 16,933,111 | 17,054,564 | RGD:6480464 | CTD | |
| G | Maf | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) |
|
increases expression | ISO | 19 | 45,859,510 | 45,861,454 | RGD:6480464 | CTD | |
| G | Maff | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
multiple interactions | ISO | 7 | 117,328,924 | 117,340,276 | RGD:6480464 | CTD | |
| G | Map2k3 | mitogen activated protein kinase kinase 3 |
|
multiple interactions | ISO | 10 | 47,075,270 | 47,096,617 | RGD:6480464 | CTD | |
| G | Map2k6 | mitogen-activated protein kinase kinase 6 |
|
multiple interactions | ISO | 10 | 99,859,684 | 99,974,446 | RGD:6480464 | CTD | |
| G | Map3k11 | mitogen-activated protein kinase kinase kinase 11 |
|
increases expression | ISO | 1 | 208,312,955 | 208,326,289 | RGD:6480464 | CTD | |
| G | Map3k5 | mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions | ISO | 1 | 15,205,361 | 15,346,422 | RGD:6480464 | CTD | |
| G | Map3k8 | mitogen-activated protein kinase kinase kinase 8 |
|
multiple interactions | ISO | 17 | 61,910,179 | 61,930,459 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
increases phosphorylation | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
increases phosphorylation | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
increases phosphorylation | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk1 | mitogen activated protein kinase 1 |
|
multiple interactions | ISO | 11 | 85,968,732 | 86,030,387 | RGD:6480464 | CTD | |
| G | Mapk14 | mitogen activated protein kinase 14 |
|
affects expression | EXP | 20 | 6,939,249 | 7,000,378 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
increases phosphorylation | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapk3 | mitogen activated protein kinase 3 |
|
multiple interactions | ISO | 1 | 185,935,044 | 185,941,245 | RGD:6480464 | CTD | |
| G | Mapkapk2 | mitogen-activated protein kinase-activated protein kinase 2 |
|
multiple interactions | ISO | 13 | 43,994,943 | 44,041,504 | RGD:6480464 | CTD | |
| G | Marcksl1 | MARCKS-like 1 |
|
affects expression | ISO | 5 | 148,669,499 | 148,672,337 | RGD:6480464 | CTD | |
| G | Matr3 | matrin 3 |
|
decreases expression | ISO | 18 | 28,171,639 | 28,215,659 | RGD:6480464 | CTD | |
| G | Mbnl2 | muscleblind-like splicing regulator 2 |
|
multiple interactions | ISO | 15 | 105,356,456 | 105,514,135 | RGD:6480464 | CTD | |
| G | Mcpt1 | mast cell protease 1 |
|
affects expression | EXP | 15 | 34,270,481 | 34,273,035 | RGD:6480464 | CTD | |
| G | Mcpt4 | mast cell protease 4 |
|
affects expression | EXP | 15 | 34,167,643 | 34,170,264 | RGD:6480464 | CTD | |
| G | Mctp1 | multiple C2 domains, transmembrane 1 |
|
increases expression | ISO | 2 | 3,652,722 | 4,354,754 | RGD:6480464 | CTD | |
| G | Mdfic | MyoD family inhibitor domain containing |
|
affects expression | ISO | 4 | 41,241,856 | 41,321,515 | RGD:6480464 | CTD | |
| G | Mdfic | MyoD family inhibitor domain containing |
|
multiple interactions | ISO | 4 | 41,241,856 | 41,321,515 | RGD:6480464 | CTD | |
| G | Mettl7a | methyltransferase like 7A | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Mettl7a | methyltransferase like 7A | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Mfap5 | microfibrillar associated protein 5 |
|
multiple interactions | ISO | 4 | 158,959,286 | 158,981,967 | RGD:6480464 | CTD | |
| G | Mfap5 | microfibrillar associated protein 5 |
|
affects expression | ISO | 4 | 158,959,286 | 158,981,967 | RGD:6480464 | CTD | |
| G | Mgp | matrix Gla protein |
|
decreases expression | ISO | 4 | 173,910,595 | 173,913,917 | RGD:6480464 | CTD | |
| G | Mki67 | antigen identified by monoclonal antibody Ki-67 |
|
decreases expression | ISO | 1 | 195,310,027 | 195,336,224 | RGD:6480464 | CTD | |
| G | Mmp12 | matrix metallopeptidase 12 |
|
affects expression | ISO | 8 | 4,249,938 | 4,259,675 | RGD:6480464 | CTD | |
| G | Mmp12 | matrix metallopeptidase 12 |
|
multiple interactions | ISO | 8 | 4,249,938 | 4,259,675 | RGD:6480464 | CTD | |
| G | Mmp2 | matrix metallopeptidase 2 |
|
affects expression | EXP | 19 | 15,246,036 | 15,275,061 | RGD:6480464 | CTD | |
| G | Mmp9 | matrix metallopeptidase 9 |
|
decreases expression | ISO | 3 | 155,985,473 | 155,993,433 | RGD:6480464 | CTD | |
| G | Mmp9 | matrix metallopeptidase 9 |
|
decreases activity | ISO | 3 | 155,985,473 | 155,993,433 | RGD:6480464 | CTD | |
| G | Mn1 | meningioma 1 |
|
multiple interactions | ISO | 12 | 45,318,155 | 45,355,115 | RGD:6480464 | CTD | |
| G | Mpo | myeloperoxidase |
|
multiple interactions | EXP | 10 | 76,085,872 | 76,097,012 | RGD:6480464 | CTD | |
| G | Mpped2 | metallophosphoesterase domain containing 2 |
|
multiple interactions | ISO | 3 | 92,197,073 | 92,370,714 | RGD:6480464 | CTD | |
| G | Mr1 | major histocompatibility complex, class I-related |
|
increases expression | ISO | 13 | 70,089,637 | 70,107,384 | RGD:6480464 | CTD | |
| G | Mrpl33 | mitochondrial ribosomal protein L33 |
|
affects expression | ISO | 6 | 24,870,269 | 24,878,462 | RGD:6480464 | CTD | |
| G | Msmb | microseminoprotein, beta |
|
multiple interactions | ISO | 16 | 7,619,432 | 7,640,019 | RGD:6480464 | CTD | |
| G | Msmb | microseminoprotein, beta |
|
affects expression | ISO | 16 | 7,619,432 | 7,640,019 | RGD:6480464 | CTD | |
| G | Msmb | microseminoprotein, beta |
|
multiple interactions | ISO | 16 | 7,619,432 | 7,640,019 | RGD:6480464 | CTD | |
| G | Mst1 | Macrophage stimulating 1 (hepatocyte growth factor-like) |
|
increases expression | ISO | 8 | 113,348,203 | 113,352,773 | RGD:6480464 | CTD | |
| G | Mst4 | serine/threonine protein kinase MST4 |
|
decreases expression | ISO | X | 137,577,961 | 137,627,511 | RGD:6480464 | CTD | |
| G | Mt2A | metallothionein 2A |
|
increases expression | ISO | 19 | 11,267,811 | 11,268,585 | RGD:6480464 | CTD | |
| G | Mthfr | methylenetetrahydrofolate reductase (NAD(P)H) |
|
decreases expression | ISO | 5 | 165,112,850 | 165,126,885 | RGD:6480464 | CTD | |
| G | Muc1 | mucin 1, cell surface associated |
|
increases expression | ISO | 2 | 181,399,482 | 181,403,640 | RGD:6480464 | CTD | |
| G | Muc1 | mucin 1, cell surface associated |
|
affects expression | EXP | 2 | 181,399,482 | 181,403,640 | RGD:6480464 | CTD | |
| G | Mybl1 | myeloblastosis oncogene-like 1 |
|
multiple interactions | ISO | 5 | 9,136,980 | 9,170,799 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
decreases expression | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
decreases expression | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myc | myelocytomatosis oncogene |
|
decreases expression | ISO | 7 | 98,953,142 | 98,958,060 | RGD:6480464 | CTD | |
| G | Myl9 | myosin, light chain 9, regulatory |
|
affects expression | EXP | 3 | 147,190,252 | 147,193,865 | RGD:6480464 | CTD | |
| G | Myo10 | myosin X |
|
affects expression | ISO | 2 | 77,183,028 | 77,385,896 | RGD:6480464 | CTD | |
| G | Myod1 | myogenic differentiation 1 |
|
decreases expression | ISO | 1 | 96,910,190 | 96,912,900 | RGD:6480464 | CTD | |
| G | Myt1l | myelin transcription factor 1-like |
|
multiple interactions | ISO | 6 | 47,435,167 | 47,828,030 | RGD:6480464 | CTD | |
| G | Nab1 | Ngfi-A binding protein 1 |
|
multiple interactions | ISO | 9 | 46,084,090 | 46,124,259 | RGD:6480464 | CTD | |
| G | Nars | asparaginyl-tRNA synthetase |
|
decreases expression | ISO | 18 | 60,719,399 | 60,736,058 | RGD:6480464 | CTD | |
| G | Nav2 | neuron navigator 2 |
|
multiple interactions | ISO | 1 | 99,041,044 | 99,410,077 | RGD:6480464 | CTD | |
| G | Nbl1 | neuroblastoma 1, DAN family BMP antagonist | increases expression | EXP | RGD:6480464 | CTD | |||||
| G | Ncaph | non-SMC condensin I complex, subunit H |
|
decreases expression | ISO | 3 | 114,651,251 | 114,679,447 | RGD:6480464 | CTD | |
| G | Ncf2 | neutrophil cytosolic factor 2 |
|
multiple interactions | ISO | 13 | 67,806,516 | 67,834,105 | RGD:6480464 | CTD | |
| G | Ncf2 | neutrophil cytosolic factor 2 |
|
affects expression | ISO | 13 | 67,806,516 | 67,834,105 | RGD:6480464 | CTD | |
| G | Ncf2 | neutrophil cytosolic factor 2 |
|
multiple interactions | ISO | 13 | 67,806,516 | 67,834,105 | RGD:6480464 | CTD | |
| G | Ncl | nucleolin |
|
decreases expression | ISO | 9 | 85,112,752 | 85,121,276 | RGD:6480464 | CTD | |
| G | Ncoa1 | nuclear receptor coactivator 1 |
|
multiple interactions | ISO | 6 | 27,224,396 | 27,473,926 | RGD:6480464 | CTD | |
| G | Ncoa1 | nuclear receptor coactivator 1 |
|
increases expression | ISO | 6 | 27,224,396 | 27,473,926 | RGD:6480464 | CTD | |
| G | Ncoa1 | nuclear receptor coactivator 1 |
|
multiple interactions | ISO | 6 | 27,224,396 | 27,473,926 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
multiple interactions | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa2 | nuclear receptor coactivator 2 |
|
increases expression | ISO | 5 | 5,197,891 | 5,275,776 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
multiple interactions | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa3 | nuclear receptor coactivator 3 |
|
multiple interactions | ISO | 3 | 157,168,492 | 157,196,566 | RGD:6480464 | CTD | |
| G | Ncoa4 | nuclear receptor coactivator 4 |
|
affects expression | ISO | 16 | 7,642,116 | 7,662,460 | RGD:6480464 | CTD | |
| G | Ncoa4 | nuclear receptor coactivator 4 |
|
multiple interactions | ISO | 16 | 7,642,116 | 7,662,460 | RGD:6480464 | CTD | |
| G | Ncor2 | nuclear receptor co-repressor 2 |
|
multiple interactions | ISO | 12 | 32,617,643 | 32,725,753 | RGD:6480464 | CTD | |
| G | Ncor2 | nuclear receptor co-repressor 2 |
|
decreases expression | ISO | 12 | 32,617,643 | 32,725,753 | RGD:6480464 | CTD | |
| G | Ndrg4 | NDRG family member 4 |
|
multiple interactions | ISO | 19 | 9,808,017 | 9,818,974 | RGD:6480464 | CTD | |
| G | Ndufa2 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 |
|
affects expression | ISO | 18 | 29,441,774 | 29,443,863 | RGD:6480464 | CTD | |
| G | Nefl | neurofilament, light polypeptide |
|
affects expression | ISO | 15 | 47,636,303 | 47,640,176 | RGD:6480464 | CTD | |
| G | Nek7 | NIMA-related kinase 7 |
|
affects expression | ISO | 13 | 51,679,191 | 51,942,636 | RGD:6480464 | CTD | |
| G | Nf1 | neurofibromin 1 |
|
increases expression | ISO | 10 | 65,574,833 | 65,766,305 | RGD:6480464 | CTD | |
| G | Nfatc1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
|
multiple interactions | ISO | 18 | 77,498,654 | 77,581,231 | RGD:6480464 | CTD | |
| G | Nfe2l1 | nuclear factor, erythroid derived 2,-like 1 |
|
increases expression | ISO | 10 | 85,570,238 | 85,577,636 | RGD:6480464 | CTD | |
| G | Nfil3 | nuclear factor, interleukin 3 regulated |
|
affects expression | ISO | 17 | 18,092,489 | 18,107,708 | RGD:6480464 | CTD | |
| G | Nfil3 | nuclear factor, interleukin 3 regulated |
|
multiple interactions | ISO | 17 | 18,092,489 | 18,107,708 | RGD:6480464 | CTD | |
| G | Nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
affects expression | ISO | 6 | 75,729,302 | 75,732,475 | RGD:6480464 | CTD | |
| G | Nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions | ISO | 6 | 75,729,302 | 75,732,475 | RGD:6480464 | CTD | |
| G | Nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression | ISO | 6 | 75,729,302 | 75,732,475 | RGD:6480464 | CTD | |
| G | Nfkbie | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
|
multiple interactions | ISO | 9 | 11,044,112 | 11,050,948 | RGD:6480464 | CTD | |
| G | Ninj1 | ninjurin 1 |
|
multiple interactions | ISO | 17 | 21,410,701 | 21,419,472 | RGD:6480464 | CTD | |
| G | Nlrp3 | NLR family, pyrin domain containing 3 |
|
multiple interactions | ISO | 10 | 45,850,224 | 45,874,533 | RGD:6480464 | CTD | |
| G | Nme6 | NME/NM23 nucleoside diphosphate kinase 6 |
|
affects expression | EXP | 8 | 114,205,773 | 114,212,486 | RGD:6480464 | CTD | |
| G | Nos2 | nitric oxide synthase 2, inducible |
|
multiple interactions | EXP | 10 | 65,036,884 | 65,072,453 | RGD:6480464 | CTD | |
| G | Nos2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 10 | 65,036,884 | 65,072,453 | RGD:6480464 | CTD | |
| G | Nos2 | nitric oxide synthase 2, inducible |
|
decreases expression | ISO | 10 | 65,036,884 | 65,072,453 | RGD:6480464 | CTD | |
| G | Nos3 | nitric oxide synthase 3, endothelial cell |
|
increases expression | EXP | 4 | 6,158,847 | 6,179,441 | RGD:6480464 | CTD | |
| G | Notch3 | notch 3 |
|
affects expression | ISO | 7 | 12,688,267 | 12,740,015 | RGD:6480464 | CTD | |
| G | Nov | nephroblastoma overexpressed |
|
multiple interactions | ISO | 7 | 91,162,676 | 91,169,696 | RGD:6480464 | CTD | |
| G | Npepo | aminopeptidase O |
|
multiple interactions | ISO | 17 | 7,353,426 | 7,624,936 | RGD:6480464 | CTD | |
| G | Npm1 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
decreases expression | ISO | 10 | 18,051,990 | 18,062,714 | RGD:6480464 | CTD | |
| G | Npr2 | natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
|
affects expression | ISO | 5 | 60,107,563 | 60,127,960 | RGD:6480464 | CTD | |
| G | Npr2 | natriuretic peptide receptor B/guanylate cyclase B (atrionatriuretic peptide receptor B) |
|
multiple interactions | ISO | 5 | 60,107,563 | 60,127,960 | RGD:6480464 | CTD | |
| G | Nr1d1 | nuclear receptor subfamily 1, group D, member 1 |
|
multiple interactions | ISO | 10 | 87,541,246 | 87,548,186 | RGD:6480464 | CTD | |
| G | Nr2f6 | nuclear receptor subfamily 2, group F, member 6 |
|
affects expression | ISO | 16 | 18,535,181 | 18,542,627 | RGD:6480464 | CTD | |
| G | Nr2f6 | nuclear receptor subfamily 2, group F, member 6 |
|
multiple interactions | ISO | 16 | 18,535,181 | 18,542,627 | RGD:6480464 | CTD | |
| G | Nr3c1 | nuclear receptor subfamily 3, group C, member 1 |
|
multiple interactions | ISO | 18 | 32,371,496 | 32,459,145 | RGD:6480464 | CTD | |
| G | Nr4a1 | nuclear receptor subfamily 4, group A, member 1 |
|
increases expression | ISO | 7 | 140,012,807 | 140,020,590 | RGD:6480464 | CTD | |
| G | Nr4a3 | nuclear receptor subfamily 4, group A, member 3 |
|
multiple interactions | ISO | 5 | 64,713,468 | 64,753,311 | RGD:6480464 | CTD | |
| G | Nrep | neuronal regeneration related protein |
|
affects expression | ISO | 18 | 25,842,127 | 25,868,219 | RGD:6480464 | CTD | |
| G | Nrf1 | nuclear respiratory factor 1 |
|
increases expression | ISO | 4 | 56,949,553 | 57,048,149 | RGD:6480464 | CTD | |
| G | Nrf1 | nuclear respiratory factor 1 |
|
multiple interactions | ISO | 4 | 56,949,553 | 57,048,149 | RGD:6480464 | CTD | |
| G | Nrg2 | neuregulin 2 |
|
increases expression | ISO | 18 | 28,650,097 | 28,828,772 | RGD:6480464 | CTD | |
| G | Ns5atp9 | NS5A (hepatitis C virus) transactivated protein 9 |
|
decreases expression | ISO | 8 | 70,159,283 | 70,172,116 | RGD:6480464 | CTD | |
| G | Nuak1 | NUAK family, SNF1-like kinase, 1 |
|
affects expression | ISO | 7 | 21,461,413 | 21,529,068 | RGD:6480464 | CTD | |
| G | Nuak1 | NUAK family, SNF1-like kinase, 1 |
|
multiple interactions | ISO | 7 | 21,461,413 | 21,529,068 | RGD:6480464 | CTD | |
| G | Nup160 | nucleoporin 160 |
|
increases expression | ISO | 3 | 75,041,873 | 75,102,540 | RGD:6480464 | CTD | |
| G | Nus1 | nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae) |
|
decreases expression | ISO | 20 | 31,143,886 | 31,170,668 | RGD:6480464 | CTD | |
| G | Nxf1 | nuclear RNA export factor 1 |
|
affects expression | EXP | 1 | 211,428,605 | 211,441,798 | RGD:6480464 | CTD | |
| G | Ocln | occludin |
|
multiple interactions | ISO | 2 | 31,317,090 | 31,367,485 | RGD:6480464 | CTD | |
| G | Olfml2a | olfactomedin-like 2A |
|
affects expression | ISO | 3 | 18,731,165 | 18,751,940 | RGD:6480464 | CTD | |
| G | Olr1361 | olfactory receptor 1361 |
|
affects expression | EXP | 10 | 12,199,166 | 12,200,107 | RGD:6480464 | CTD | |
| G | Olr1696 | olfactory receptor 1696 |
|
affects expression | EXP | 20 | 697,146 | 698,111 | RGD:6480464 | CTD | |
| G | Osbpl3 | oxysterol binding protein-like 3 |
|
multiple interactions | ISO | 4 | 78,521,743 | 78,600,559 | RGD:6480464 | CTD | |
| G | Osbpl7 | oxysterol binding protein-like 7 |
|
increases expression | ISO | 10 | 85,771,941 | 85,789,490 | RGD:6480464 | CTD | |
| G | Otub2 | OTU domain, ubiquitin aldehyde binding 2 |
|
multiple interactions | ISO | 6 | 127,679,755 | 127,698,318 | RGD:6480464 | CTD | |
| G | Palld | palladin, cytoskeletal associated protein |
|
affects expression | ISO | 16 | 31,144,028 | 31,144,544 | RGD:6480464 | CTD | |
| G | Papola | poly (A) polymerase alpha |
|
affects expression | EXP | 6 | 129,936,041 | 129,988,481 | RGD:6480464 | CTD | |
| G | Pappa | pregnancy-associated plasma protein A |
|
increases expression | ISO | 5 | 81,826,649 | 82,096,446 | RGD:6480464 | CTD | |
| G | Pawr | PRKC, apoptosis, WT1, regulator |
|
increases expression | ISO | 7 | 47,040,162 | 47,119,613 | RGD:6480464 | CTD | |
| G | Pcdh7 | protocadherin 7 |
|
multiple interactions | ISO | 14 | 56,609,036 | 57,323,892 | RGD:6480464 | CTD | |
| G | Pcdhga3 | protocadherin gamma subfamily A, 3 |
|
increases expression | ISO | 18 | 30,580,301 | 30,754,205 | RGD:6480464 | CTD | |
| G | Pcna | proliferating cell nuclear antigen |
|
affects expression | ISO | 3 | 120,008,715 | 120,012,589 | RGD:6480464 | CTD | |
| G | Pcna | proliferating cell nuclear antigen |
|
increases expression | ISO | 3 | 120,008,715 | 120,012,589 | RGD:6480464 | CTD | |
| G | Pcna | proliferating cell nuclear antigen |
|
decreases expression | ISO | 3 | 120,008,715 | 120,012,589 | RGD:6480464 | CTD | |
| G | Pcna | proliferating cell nuclear antigen |
|
decreases expression | EXP | 3 | 120,008,715 | 120,012,589 | RGD:6480464 | CTD | |
| G | Pcolce | procollagen C-endopeptidase enhancer |
|
affects expression | EXP | 12 | 19,672,505 | 19,678,821 | RGD:6480464 | CTD | |
| G | Pcolce | procollagen C-endopeptidase enhancer |
|
increases expression | EXP | 12 | 19,672,505 | 19,678,821 | RGD:6480464 | CTD | |
| G | Pctp | phosphatidylcholine transfer protein |
|
multiple interactions | ISO | 10 | 78,400,328 | 78,420,774 | RGD:6480464 | CTD | |
| G | Pdcd5 | programmed cell death 5 |
|
increases expression | ISO | 1 | 88,194,319 | 88,199,647 | RGD:6480464 | CTD | |
| G | Pde3b | phosphodiesterase 3B, cGMP-inhibited |
|
increases expression | ISO | 1 | 172,409,282 | 172,577,108 | RGD:6480464 | CTD | |
| G | Pde4d | phosphodiesterase 4D, cAMP-specific |
|
increases expression | ISO | 2 | 40,196,097 | 41,311,012 | RGD:6480464 | CTD | |
| G | Pde5a | phosphodiesterase 5A, cGMP-specific |
|
decreases expression | ISO | 2 | 219,410,394 | 219,550,910 | RGD:6480464 | CTD | |
| G | Pdgfra | platelet derived growth factor receptor, alpha polypeptide |
|
affects expression | ISO | 14 | 35,369,422 | 35,418,126 | RGD:6480464 | CTD | |
| G | Pdgfrb | platelet derived growth factor receptor, beta polypeptide |
|
affects expression | ISO | 18 | 57,014,475 | 57,053,581 | RGD:6480464 | CTD | |
| G | Pdlim3 | PDZ and LIM domain 3 |
|
multiple interactions | ISO | 16 | 49,637,068 | 49,668,802 | RGD:6480464 | CTD | |
| G | Pdp1 | pyruvate dehyrogenase phosphatase catalytic subunit 1 |
|
multiple interactions | ISO | 5 | 26,234,414 | 26,240,301 | RGD:6480464 | CTD | |
| G | Pdyn | prodynorphin |
|
affects expression | EXP | 3 | 117,291,025 | 117,303,367 | RGD:6480464 | CTD | |
| G | Pdzk1 | PDZ domain containing 1 |
|
multiple interactions | ISO | 2 | 191,643,593 | 191,675,995 | RGD:6480464 | CTD | |
| G | Pex5 | peroxisomal biogenesis factor 5 |
|
affects expression | EXP | 4 | 160,567,258 | 160,595,985 | RGD:6480464 | CTD | |
| G | Pfkfb3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
multiple interactions | ISO | 17 | 78,241,182 | 78,268,272 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
decreases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
decreases expression | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
increases expression | EXP | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Pgr | progesterone receptor |
|
multiple interactions | ISO | 8 | 5,784,717 | 5,845,901 | RGD:6480464 | CTD | |
| G | Phc2 | polyhomeotic homolog 2 (Drosophila) |
|
multiple interactions | ISO | 5 | 147,930,703 | 147,978,856 | RGD:6480464 | CTD | |
| G | Phf11 | PHD finger protein 11 |
|
multiple interactions | ISO | 15 | 38,443,971 | 38,477,944 | RGD:6480464 | CTD | |
| G | Pias3 | protein inhibitor of activated STAT, 3 |
|
affects expression | EXP | 2 | 191,499,057 | 191,507,221 | RGD:6480464 | CTD | |
| G | Pigr | polymeric immunoglobulin receptor |
|
affects expression | EXP | 13 | 43,785,845 | 43,819,331 | RGD:6480464 | CTD | |
| G | Pim1 | pim-1 oncogene |
|
affects expression | ISO | 20 | 7,817,403 | 7,821,800 | RGD:6480464 | CTD | |
| G | Pitpnc1 | phosphatidylinositol transfer protein, cytoplasmic 1 |
|
multiple interactions | ISO | 10 | 96,594,391 | 96,871,091 | RGD:6480464 | CTD | |
| G | Pla2g10 | phospholipase A2, group X |
|
multiple interactions | ISO | 10 | 26,035 | 37,273 | RGD:6480464 | CTD | |
| G | Pla2g7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) |
|
decreases expression | ISO | 9 | 13,057,988 | 13,100,289 | RGD:6480464 | CTD | |
| G | Plat | plasminogen activator, tissue |
|
increases expression | ISO | 16 | 73,711,323 | 73,736,328 | RGD:6480464 | CTD | |
| G | Plau | plasminogen activator, urokinase |
|
decreases expression | ISO | 15 | 3,680,072 | 3,686,232 | RGD:6480464 | CTD | |
| G | Plau | plasminogen activator, urokinase |
|
multiple interactions | ISO | 15 | 3,680,072 | 3,686,232 | RGD:6480464 | CTD | |
| G | Plaur | plasminogen activator, urokinase receptor |
|
decreases expression | ISO | 1 | 79,708,646 | 79,712,881 | RGD:6480464 | CTD | |
| G | Plekhs1 | pleckstrin homology domain containing, family S member 1 |
|
multiple interactions | ISO | 1 | 262,740,491 | 262,770,180 | RGD:6480464 | CTD | |
| G | Plk3 | polo-like kinase 3 |
|
multiple interactions | ISO | 5 | 137,443,540 | 137,448,715 | RGD:6480464 | CTD | |
| G | Plxnd1 | plexin D1 |
|
increases expression | ISO | 4 | 152,080,259 | 152,119,942 | RGD:6480464 | CTD | |
| G | Pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression | ISO | 18 | 62,914,845 | 62,918,832 | RGD:6480464 | CTD | |
| G | Pmp22 | peripheral myelin protein 22 |
|
multiple interactions | ISO | 10 | 49,305,835 | 49,335,864 | RGD:6480464 | CTD | |
| G | Pms2 | postmeiotic segregation increased 2 (S. cerevisiae) |
|
increases expression | ISO | 12 | 11,004,507 | 11,028,754 | RGD:6480464 | CTD | |
| G | Podxl | podocalyxin-like |
|
affects expression | ISO | 4 | 58,611,904 | 58,658,598 | RGD:6480464 | CTD | |
| G | Polm | polymerase (DNA directed), mu |
|
increases expression | ISO | 14 | 86,491,716 | 86,501,294 | RGD:6480464 | CTD | |
| G | Polr2b | polymerase (RNA) II (DNA directed) polypeptide B |
|
decreases expression | ISO | 14 | 33,069,966 | 33,107,615 | RGD:6480464 | CTD | |
| G | Ppap2a | phosphatidic acid phosphatase type 2A |
|
affects expression | EXP | 2 | 44,183,290 | 44,247,787 | RGD:6480464 | CTD | |
| G | Ppap2b | phosphatidic acid phosphatase type 2B |
|
multiple interactions | ISO | 5 | 126,121,416 | 126,197,099 | RGD:6480464 | CTD | |
| G | Ppap2b | phosphatidic acid phosphatase type 2B |
|
affects expression | ISO | 5 | 126,121,416 | 126,197,099 | RGD:6480464 | CTD | |
| G | Ppm1d | protein phosphatase, Mg2+/Mn2+ dependent, 1D |
|
decreases expression | ISO | 10 | 73,575,506 | 73,612,063 | RGD:6480464 | CTD | |
| G | Ppp1r10 | protein phosphatase 1, regulatory subunit 10 |
|
increases expression | ISO | 20 | 2,940,605 | 2,984,636 | RGD:6480464 | CTD | |
| G | Ppp1r13b | protein phosphatase 1, regulatory subunit 13B |
|
decreases expression | ISO | 6 | 136,620,379 | 136,659,341 | RGD:6480464 | CTD | |
| G | Ppp1r15a | protein phosphatase 1, regulatory subunit 15A |
|
affects expression | EXP | 1 | 95,994,023 | 95,997,080 | RGD:6480464 | CTD | |
| G | Ppp1r15a | protein phosphatase 1, regulatory subunit 15A |
|
increases expression | ISO | 1 | 95,994,023 | 95,997,080 | RGD:6480464 | CTD | |
| G | Prdx2 | peroxiredoxin 2 |
|
affects expression | EXP | 19 | 24,836,199 | 24,841,390 | RGD:6480464 | CTD | |
| G | Prkcz | protein kinase C, zeta |
|
multiple interactions | ISO | 5 | 172,061,825 | 172,172,793 | RGD:6480464 | CTD | |
| G | Prkdc | protein kinase, DNA activated, catalytic polypeptide |
|
decreases expression | ISO | 11 | 86,951,420 | 87,169,229 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
multiple interactions | ISO | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Prl | prolactin |
|
decreases secretion | ISO | 17 | 44,699,101 | 44,709,162 | RGD:6480464 | CTD | |
| G | Proc | protein C |
|
decreases activity | ISO | 18 | 24,563,368 | 24,573,715 | RGD:6480464 | CTD | |
| G | Pros1 | protein S (alpha) | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Pros1 | protein S (alpha) | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Prpf4b | PRP4 pre-mRNA processing factor 4 homolog B (yeast) |
|
decreases expression | ISO | 17 | 36,319,606 | 36,350,616 | RGD:6480464 | CTD | |
| G | Psap | prosaposin |
|
affects expression | EXP | 20 | 27,595,048 | 27,621,574 | RGD:6480464 | CTD | |
| G | Psmd14 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 |
|
decreases expression | ISO | 3 | 43,660,136 | 43,699,412 | RGD:6480464 | CTD | |
| G | Psmd6 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
|
decreases expression | ISO | 15 | 12,650,570 | 12,660,487 | RGD:6480464 | CTD | |
| G | Psme1 | proteasome (prosome, macropain) activator subunit 1 |
|
affects expression | EXP | 15 | 33,712,892 | 33,715,769 | RGD:6480464 | CTD | |
| G | Psme4 | proteasome (prosome, macropain) activator subunit 4 |
|
decreases expression | ISO | 14 | 111,892,871 | 111,997,184 | RGD:6480464 | CTD | |
| G | Ptgds | prostaglandin D2 synthase (brain) |
|
multiple interactions | ISO | 3 | 3,632,683 | 3,635,617 | RGD:6480464 | CTD | |
| G | Ptger3 | prostaglandin E receptor 3 (subtype EP3) |
|
multiple interactions | ISO | 2 | 255,680,691 | 255,759,202 | RGD:6480464 | CTD | |
| G | Ptges | prostaglandin E synthase |
|
multiple interactions | ISO | 3 | 9,946,194 | 9,957,538 | RGD:6480464 | CTD | |
| G | Ptgfrn | prostaglandin F2 receptor inhibitor |
|
affects expression | EXP | 2 | 196,091,505 | 196,162,950 | RGD:6480464 | CTD | |
| G | Ptgis | prostaglandin I2 (prostacyclin) synthase |
|
affects expression | EXP | 3 | 158,356,878 | 158,387,984 | RGD:6480464 | CTD | |
| G | Ptgs2 | prostaglandin-endoperoxide synthase 2 |
|
multiple interactions | ISO | 13 | 64,427,288 | 64,432,978 | RGD:6480464 | CTD | |
| G | Ptgs2 | prostaglandin-endoperoxide synthase 2 |
|
multiple interactions | ISO | 13 | 64,427,288 | 64,432,978 | RGD:6480464 | CTD | |
| G | Ptgs2 | prostaglandin-endoperoxide synthase 2 |
|
decreases expression | ISO | 13 | 64,427,288 | 64,432,978 | RGD:6480464 | CTD | |
| G | Ptgs2 | prostaglandin-endoperoxide synthase 2 |
|
increases expression | ISO | 13 | 64,427,288 | 64,432,978 | RGD:6480464 | CTD | |
| G | Ptgs2 | prostaglandin-endoperoxide synthase 2 |
|
increases expression | ISO | 13 | 64,427,288 | 64,432,978 | RGD:6480464 | CTD | |
| G | Ptgs2 | prostaglandin-endoperoxide synthase 2 |
|
multiple interactions | EXP | 13 | 64,427,288 | 64,432,978 | RGD:6480464 | CTD | |
| G | Pth | parathyroid hormone |
|
decreases expression | ISO | 1 | 171,240,596 | 171,243,528 | RGD:6480464 | CTD | |
| G | Ptp4a3 | protein tyrosine phosphatase type IVA, member 3 |
|
multiple interactions | ISO | 7 | 111,462,191 | 111,468,045 | RGD:6480464 | CTD | |
| G | Ptpn13 | protein tyrosine phosphatase, non-receptor type 13 |
|
increases expression | ISO | 14 | 7,298,209 | 7,433,464 | RGD:6480464 | CTD | |
| G | Ptpn4 | protein tyrosine phosphatase, non-receptor type 4 |
|
affects expression | ISO | 13 | 32,430,875 | 32,611,163 | RGD:6480464 | CTD | |
| G | Ptpn6 | protein tyrosine phosphatase, non-receptor type 6 |
|
decreases activity | ISO | 4 | 160,843,699 | 160,868,856 | RGD:6480464 | CTD | |
| G | Ptpre | protein tyrosine phosphatase, receptor type, E |
|
affects expression | ISO | 1 | 195,263,489 | 195,303,249 | RGD:6480464 | CTD | |
| G | Ptpre | protein tyrosine phosphatase, receptor type, E |
|
multiple interactions | ISO | 1 | 195,263,489 | 195,303,249 | RGD:6480464 | CTD | |
| G | Ptprh | protein tyrosine phosphatase, receptor type, H |
|
affects expression | ISO | 1 | 67,960,564 | 68,004,280 | RGD:6480464 | CTD | |
| G | Ptprr | protein tyrosine phosphatase, receptor type, R |
|
affects expression | ISO | 7 | 55,324,246 | 55,612,945 | RGD:6480464 | CTD | |
| G | Ptx3 | pentraxin 3, long |
|
multiple interactions | ISO | 2 | 156,089,917 | 156,095,726 | RGD:6480464 | CTD | |
| G | Pvrl1 | poliovirus receptor-related 1 |
|
affects expression | EXP | 8 | 46,739,657 | 46,799,051 | RGD:6480464 | CTD | |
| G | Pyy | peptide YY (mapped) |
|
increases expression | ISO | 10 | 91,174,365 | 91,175,488 | RGD:6480464 | CTD | |
| G | Qk | quaking |
|
multiple interactions | ISO | 1 | 44,922,562 | 45,025,572 | RGD:6480464 | CTD | |
| G | Rab11b | RAB11B, member RAS oncogene family |
|
increases expression | ISO | 7 | 16,232,840 | 16,246,007 | RGD:6480464 | CTD | |
| G | Rab2a | RAB2A, member RAS oncogene family |
|
increases expression | ISO | 5 | 22,389,585 | 22,452,198 | RGD:6480464 | CTD | |
| G | Rab31 | RAB31, member RAS oncogene family |
|
affects expression | ISO | 9 | 104,408,546 | 104,543,084 | RGD:6480464 | CTD | |
| G | Rab40c | Rab40c, member RAS oncogene family |
|
increases expression | ISO | 10 | 15,147,861 | 15,181,653 | RGD:6480464 | CTD | |
| G | Racgap1 | Rac GTPase-activating protein 1 |
|
decreases expression | ISO | 7 | 138,366,356 | 138,395,716 | RGD:6480464 | CTD | |
| G | Rap1a | RAP1A, member of RAS oncogene family |
|
decreases expression | ISO | 2 | 200,980,324 | 201,001,561 | RGD:6480464 | CTD | |
| G | Rara | retinoic acid receptor, alpha |
|
affects expression | EXP | 10 | 87,740,479 | 87,753,265 | RGD:6480464 | CTD | |
| G | Rasa1 | RAS p21 protein activator (GTPase activating protein) 1 |
|
increases expression | EXP | 2 | 14,203,815 | 14,287,824 | RGD:6480464 | CTD | |
| G | Rasgrp1 | RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
|
multiple interactions | ISO | 3 | 103,371,879 | 103,433,010 | RGD:6480464 | CTD | |
| G | Rb1 | retinoblastoma 1 |
|
decreases expression | ISO | 15 | 53,828,881 | 53,962,099 | RGD:6480464 | CTD | |
| G | Rbbp7 | retinoblastoma binding protein 7 |
|
decreases expression | ISO | X | 52,669,703 | 52,688,332 | RGD:6480464 | CTD | |
| G | Rbm10 | RNA binding motif protein 10 |
|
increases expression | ISO | X | 12,957,747 | 12,989,619 | RGD:6480464 | CTD | |
| G | Rcan2 | regulator of calcineurin 2 |
|
multiple interactions | ISO | 9 | 12,623,121 | 12,853,302 | RGD:6480464 | CTD | |
| G | Rela | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | ISO | 1 | 208,262,669 | 208,273,148 | RGD:6480464 | CTD | |
| G | Rela | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | ISO | 1 | 208,262,669 | 208,273,148 | RGD:6480464 | CTD | |
| G | Rela | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity | ISO | 1 | 208,262,669 | 208,273,148 | RGD:6480464 | CTD | |
| G | Rela | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions | EXP | 1 | 208,262,669 | 208,273,148 | RGD:6480464 | CTD | |
| G | Ret | ret proto-oncogene |
|
multiple interactions | ISO | 4 | 154,448,179 | 154,491,103 | RGD:6480464 | CTD | |
| G | Rfk | riboflavin kinase |
|
affects expression | ISO | 1 | 220,924,547 | 220,932,059 | RGD:6480464 | CTD | |
| G | Rfk | riboflavin kinase |
|
multiple interactions | ISO | 1 | 220,924,547 | 220,932,059 | RGD:6480464 | CTD | |
| G | Rftn1 | raftlin lipid raft linker 1 |
|
multiple interactions | ISO | 9 | 6,008,948 | 6,207,477 | RGD:6480464 | CTD | |
| G | Rgl1 | ral guanine nucleotide dissociation stimulator,-like 1 |
|
multiple interactions | ISO | 13 | 67,468,218 | 67,754,947 | RGD:6480464 | CTD | |
| G | Rgs10 | regulator of G-protein signaling 10 |
|
affects expression | ISO | 1 | 187,622,488 | 187,664,295 | RGD:6480464 | CTD | |
| G | Rgs13 | regulator of G-protein signaling 13 |
|
affects expression | ISO | 13 | 58,016,245 | 58,042,762 | RGD:6480464 | CTD | |
| G | Rgs16 | regulator of G-protein signaling 16 |
|
multiple interactions | ISO | 13 | 68,807,863 | 68,811,307 | RGD:6480464 | CTD | |
| G | Rgs4 | regulator of G-protein signaling 4 |
|
multiple interactions | ISO | 13 | 85,533,882 | 85,540,173 | RGD:6480464 | CTD | |
| G | Rhoa | ras homolog family member A | decreases expression | EXP | RGD:6480464 | CTD | |||||
| G | Rhobtb3 | Rho-related BTB domain containing 3 |
|
affects expression | ISO | 2 | 2,911,820 | 2,967,473 | RGD:6480464 | CTD | |
| G | Rhobtb3 | Rho-related BTB domain containing 3 |
|
multiple interactions | ISO | 2 | 2,911,820 | 2,967,473 | RGD:6480464 | CTD | |
| G | Rnd3 | Rho family GTPase 3 |
|
decreases expression | ISO | 3 | 32,101,433 | 32,118,785 | RGD:6480464 | CTD | |
| G | Rock1 | Rho-associated coiled-coil containing protein kinase 1 |
|
decreases expression | EXP | 18 | 1,391,751 | 1,511,865 | RGD:6480464 | CTD | |
| G | Rock2 | Rho-associated coiled-coil containing protein kinase 2 |
|
decreases expression | EXP | 6 | 40,581,247 | 40,672,854 | RGD:6480464 | CTD | |
| G | Rom1 | retinal outer segment membrane protein 1 |
|
increases expression | ISO | 1 | 211,604,295 | 211,606,303 | RGD:6480464 | CTD | |
| G | Rps6ka2 | ribosomal protein S6 kinase polypeptide 2 |
|
multiple interactions | ISO | 1 | 47,424,106 | 47,560,373 | RGD:6480464 | CTD | |
| G | Rrad | Ras-related associated with diabetes |
|
multiple interactions | ISO | 19 | 272,791 | 275,957 | RGD:6480464 | CTD | |
| G | Rras | related RAS viral (r-ras) oncogene homolog |
|
affects expression | ISO | 1 | 95,490,730 | 95,495,462 | RGD:6480464 | CTD | |
| G | Rrm1-ps1 | ribonucleotide reductase M1, pseudogene 1 |
|
decreases expression | ISO | 14 | 77,408,781 | 77,411,150 | RGD:6480464 | CTD | |
| G | RT1-Bb | RT1 class II, locus Bb |
|
affects expression | EXP | 20 | 4,730,559 | 4,736,201 | RGD:6480464 | CTD | |
| G | Runx2 | runt-related transcription factor 2 |
|
affects expression | ISO | 9 | 11,869,234 | 12,025,219 | RGD:6480464 | CTD | |
| G | Rxrb | retinoid X receptor beta |
|
increases expression | ISO | 20 | 4,954,336 | 4,960,880 | RGD:6480464 | CTD | |
| G | Ryr1 | ryanodine receptor 1 (skeletal) |
|
affects expression | ISO | 1 | 84,116,098 | 84,254,503 | RGD:6480464 | CTD | |
| G | Safb | scaffold attachment factor B | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Sall1 | sal-like 1 (Drosophila) |
|
multiple interactions | ISO | 19 | 19,277,337 | 19,293,298 | RGD:6480464 | CTD | |
| G | Scd | stearoyl-CoA desaturase (delta-9-desaturase) |
|
affects expression | EXP | 1 | 249,358,105 | 249,371,164 | RGD:6480464 | CTD | |
| G | Scn4a | sodium channel, voltage-gated, type IV, alpha subunit |
|
affects expression | EXP | 10 | 95,710,710 | 95,760,323 | RGD:6480464 | CTD | |
| G | Scnn1a | sodium channel, nonvoltage-gated 1 alpha |
|
multiple interactions | ISO | 4 | 161,445,936 | 161,469,267 | RGD:6480464 | CTD | |
| G | Sdc1 | syndecan 1 |
|
affects expression | ISO | 6 | 32,253,352 | 32,275,812 | RGD:6480464 | CTD | |
| G | Sema3a | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
|
decreases expression | ISO | 4 | 17,575,112 | 17,790,100 | RGD:6480464 | CTD | |
| G | Sema3b | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
|
multiple interactions | ISO | 8 | 112,845,709 | 112,852,565 | RGD:6480464 | CTD | |
| G | Sema3b | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B |
|
increases expression | ISO | 8 | 112,845,709 | 112,852,565 | RGD:6480464 | CTD | |
| G | Sema3f | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3 F |
|
multiple interactions | ISO | 8 | 112,932,112 | 112,962,333 | RGD:6480464 | CTD | |
| G | Sema4b | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
|
decreases expression | ISO | 1 | 136,001,219 | 136,031,302 | RGD:6480464 | CTD | |
| G | Serpina3n | serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
multiple interactions | ISO | 6 | 128,461,775 | 128,469,309 | RGD:6480464 | CTD | |
| G | Serpinb2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
decreases expression | ISO | 13 | 13,632,596 | 13,641,605 | RGD:6480464 | CTD | |
| G | Serpinb2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
increases expression | ISO | 13 | 13,632,596 | 13,641,605 | RGD:6480464 | CTD | |
| G | Serpinb6 | serpin peptidase inhibitor, clade B (ovalbumin), member 6 |
|
multiple interactions | ISO | 17 | 37,316,389 | 37,335,124 | RGD:6480464 | CTD | |
| G | Serpinb9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
|
affects binding | ISO | 17 | 37,780,179 | 37,791,625 | RGD:6480464 | CTD | |
| G | Serpinb9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
|
multiple interactions | ISO | 17 | 37,780,179 | 37,791,625 | RGD:6480464 | CTD | |
| G | Serpine1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions | ISO | 12 | 20,931,996 | 20,942,374 | RGD:6480464 | CTD | |
| G | Serpine1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
decreases expression | ISO | 12 | 20,931,996 | 20,942,374 | RGD:6480464 | CTD | |
| G | Serpine1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression | ISO | 12 | 20,931,996 | 20,942,374 | RGD:6480464 | CTD | |
| G | Serpine2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
|
affects expression | ISO | 9 | 79,091,414 | 79,166,330 | RGD:6480464 | CTD | |
| G | Serpine2 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
|
affects expression | EXP | 9 | 79,091,414 | 79,166,330 | RGD:6480464 | CTD | |
| G | Serpinh1 | serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
affects expression | EXP | 1 | 156,666,914 | 156,674,210 | RGD:6480464 | CTD | |
| G | Sfpq | splicing factor proline/glutamine-rich |
|
decreases expression | ISO | 5 | 146,460,306 | 146,469,289 | RGD:6480464 | CTD | |
| G | Sgk1 | serum/glucocorticoid regulated kinase 1 |
|
affects expression | ISO | 1 | 23,501,257 | 23,506,651 | RGD:6480464 | CTD | |
| G | Sgk1 | serum/glucocorticoid regulated kinase 1 |
|
multiple interactions | ISO | 1 | 23,501,257 | 23,506,651 | RGD:6480464 | CTD | |
| G | Shb | Src homology 2 domain containing adaptor protein B |
|
affects expression | ISO | 5 | 61,983,643 | 62,090,620 | RGD:6480464 | CTD | |
| G | Shbg | sex hormone binding globulin |
|
increases expression | ISO | 10 | 56,432,474 | 56,435,654 | RGD:6480464 | CTD | |
| G | Shbg | sex hormone binding globulin |
|
increases expression | ISO | 10 | 56,432,474 | 56,435,654 | RGD:6480464 | CTD | |
| G | Slc17a7 | solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 |
|
decreases expression | ISO | 1 | 95,640,743 | 95,651,938 | RGD:6480464 | CTD | |
| G | Slc18a2 | solute carrier family 18 (vesicular monoamine), member 2 |
|
affects expression | EXP | 1 | 265,789,917 | 265,824,551 | RGD:6480464 | CTD | |
| G | Slc18a3 | solute carrier family 18 (vesicular acetylcholine), member 3 |
|
multiple interactions | ISO | 16 | 7,969,738 | 7,972,599 | RGD:6480464 | CTD | |
| G | Slc19a1 | solute carrier family 19 (folate transporter), member 1 |
|
affects expression | EXP | 20 | 11,984,283 | 12,001,865 | RGD:6480464 | CTD | |
| G | Slc22a5 | solute carrier family 22 (organic cation/carnitine transporter), member 5 |
|
affects expression | ISO | 10 | 39,311,729 | 39,338,718 | RGD:6480464 | CTD | |
| G | Slc25a10 | solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
|
increases expression | EXP | 10 | 109,877,811 | 109,885,272 | RGD:6480464 | CTD | |
| G | Slc26a2 | solute carrier family 26 (sulfate transporter), member 2 |
|
decreases expression | ISO | 18 | 57,170,814 | 57,184,489 | RGD:6480464 | CTD | |
| G | Slc2a3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
|
affects expression | ISO | 4 | 159,210,116 | 159,221,169 | RGD:6480464 | CTD | |
| G | Slc2a4 | solute carrier family 2 (facilitated glucose transporter), member 4 |
|
increases expression | ISO | 10 | 56,786,705 | 56,792,209 | RGD:6480464 | CTD | |
| G | Slc38a2 | solute carrier family 38, member 2 |
|
increases expression | ISO | 7 | 135,365,172 | 135,377,341 | RGD:6480464 | CTD | |
| G | Slc39a6 | solute carrier family 39 (zinc transporter), member 6 |
|
decreases expression | ISO | 18 | 16,353,725 | 16,374,267 | RGD:6480464 | CTD | |
| G | Slc3a2 | solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression | ISO | 1 | 211,375,889 | 211,390,313 | RGD:6480464 | CTD | |
| G | Slc6a3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases expression | EXP | 1 | 30,516,568 | 30,557,540 | RGD:6480464 | CTD | |
| G | Slc6a4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
affects expression | EXP | 10 | 67,134,790 | 67,155,891 | RGD:6480464 | CTD | |
| G | Slc6a4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
|
multiple interactions | EXP | 10 | 67,134,790 | 67,155,891 | RGD:6480464 | CTD | |
| G | Slc7a11 | solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression | ISO | 2 | 139,241,142 | 139,317,101 | RGD:6480464 | CTD | |
| G | Slc7a4 | solute carrier family 7 (orphan transporter), member 4 |
|
affects expression | EXP | 11 | 85,426,546 | 85,430,217 | RGD:6480464 | CTD | |
| G | Slc9a3r1 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
|
affects expression | ISO | 10 | 105,237,637 | 105,254,750 | RGD:6480464 | CTD | |
| G | Slco4c1 | solute carrier organic anion transporter family, member 4C1 |
|
multiple interactions | ISO | 9 | 96,042,701 | 96,092,537 | RGD:6480464 | CTD | |
| G | Slit1 | slit homolog 1 (Drosophila) |
|
affects expression | EXP | 1 | 246,813,909 | 246,964,408 | RGD:6480464 | CTD | |
| G | Smad7 | SMAD family member 7 |
|
affects expression | ISO | 18 | 72,294,803 | 72,323,354 | RGD:6480464 | CTD | |
| G | Smurf2 | SMAD specific E3 ubiquitin protein ligase 2 |
|
decreases expression | ISO | 10 | 96,170,590 | 96,269,365 | RGD:6480464 | CTD | |
| G | Snca | synuclein, alpha (non A4 component of amyloid precursor) |
|
affects expression | EXP | 4 | 89,613,731 | 89,722,807 | RGD:6480464 | CTD | |
| G | Snn | stannin |
|
affects expression | EXP | 10 | 4,486,038 | 4,494,711 | RGD:6480464 | CTD | |
| G | Sod2 | superoxide dismutase 2, mitochondrial |
|
multiple interactions | ISO | 1 | 41,862,997 | 41,870,327 | RGD:6480464 | CTD | |
| G | Sod3 | superoxide dismutase 3, extracellular |
|
increases expression | EXP | 14 | 63,381,447 | 63,387,180 | RGD:6480464 | CTD | |
| G | Sparc | secreted protein, acidic, cysteine-rich (osteonectin) |
|
affects expression | EXP | 10 | 40,809,730 | 40,831,481 | RGD:6480464 | CTD | |
| G | Spata13 | spermatogenesis associated 13 |
|
increases expression | ISO | 15 | 39,722,469 | 39,849,214 | RGD:6480464 | CTD | |
| G | Spn | sialophorin |
|
affects expression | EXP | 1 | 186,388,120 | 186,391,887 | RGD:6480464 | CTD | |
| G | Spock3 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
|
increases expression | ISO | 16 | 29,337,211 | 29,751,950 | RGD:6480464 | CTD | |
| G | Spp1 | secreted phosphoprotein 1 | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Sqstm1 | sequestosome 1 |
|
increases expression | EXP | 10 | 35,751,300 | 35,762,630 | RGD:6480464 | CTD | |
| G | Srebf1 | sterol regulatory element binding transcription factor 1 |
|
multiple interactions | ISO | 10 | 46,461,684 | 46,483,646 | RGD:6480464 | CTD | |
| G | Srpk2 | SRSF protein kinase 2 |
|
affects expression | EXP | 4 | 6,918,521 | 7,039,871 | RGD:6480464 | CTD | |
| G | Srsf1 | serine/arginine-rich splicing factor 1 |
|
decreases expression | ISO | 10 | 76,339,824 | 76,344,552 | RGD:6480464 | CTD | |
| G | Srsf3 | serine/arginine-rich splicing factor 3 |
|
affects expression | EXP | 20 | 7,316,649 | 7,326,580 | RGD:6480464 | CTD | |
| G | Srsf7 | serine/arginine-rich splicing factor 7 |
|
decreases expression | ISO | 6 | 3,101,772 | 3,104,433 | RGD:6480464 | CTD | |
| G | Ssh1 | slingshot protein phosphatase 1 |
|
multiple interactions | ISO | 12 | 43,660,409 | 43,714,743 | RGD:6480464 | CTD | |
| G | St3gal1 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
|
multiple interactions | ISO | 7 | 104,467,678 | 104,474,345 | RGD:6480464 | CTD | |
| G | St3gal2 | ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
|
increases expression | ISO | 19 | 40,873,202 | 40,889,072 | RGD:6480464 | CTD | |
| G | Stat1 | signal transducer and activator of transcription 1 |
|
decreases expression | ISO | 9 | 46,455,635 | 46,497,560 | RGD:6480464 | CTD | |
| G | Stat3 | signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions | ISO | 10 | 89,821,078 | 89,872,970 | RGD:6480464 | CTD | |
| G | Stbd1 | starch binding domain 1 |
|
affects expression | ISO | 14 | 17,031,752 | 17,035,157 | RGD:6480464 | CTD | |
| G | Stc2 | stanniocalcin 2 |
|
increases expression | ISO | 10 | 16,514,603 | 16,524,369 | RGD:6480464 | CTD | |
| G | Stk24 | serine/threonine kinase 24 |
|
affects expression | ISO | 15 | 106,256,862 | 106,307,134 | RGD:6480464 | CTD | |
| G | Stk24 | serine/threonine kinase 24 |
|
multiple interactions | ISO | 15 | 106,256,862 | 106,307,134 | RGD:6480464 | CTD | |
| G | Stmn1 | stathmin 1 |
|
decreases expression | ISO | 5 | 153,226,420 | 153,232,084 | RGD:6480464 | CTD | |
| G | Stx16 | syntaxin 16 |
|
increases expression | ISO | 3 | 164,995,189 | 165,022,884 | RGD:6480464 | CTD | |
| G | Stx1a | syntaxin 1A (brain) |
|
increases expression | ISO | 12 | 22,737,112 | 22,765,064 | RGD:6480464 | CTD | |
| G | Sult5a1 | sulfotransferase family 5A, member 1 |
|
affects expression | EXP | 19 | 53,472,683 | 53,498,840 | RGD:6480464 | CTD | |
| G | Sybu | syntabulin (syntaxin-interacting) |
|
multiple interactions | ISO | 7 | 80,551,448 | 80,636,458 | RGD:6480464 | CTD | |
| G | Synj2 | synaptojanin 2 |
|
multiple interactions | ISO | 1 | 40,763,794 | 40,818,491 | RGD:6480464 | CTD | |
| G | Synpo | synaptopodin |
|
multiple interactions | ISO | 18 | 56,552,991 | 56,573,981 | RGD:6480464 | CTD | |
| G | T | brachyury |
|
increases expression | ISO | 1 | 46,937,223 | 46,944,988 | RGD:6480464 | CTD | |
| G | Tacc1 | transforming, acidic coiled-coil containing protein 1 |
|
affects expression | ISO | 16 | 71,241,785 | 71,304,959 | RGD:6480464 | CTD | |
| G | Tacc1 | transforming, acidic coiled-coil containing protein 1 |
|
multiple interactions | ISO | 16 | 71,241,785 | 71,304,959 | RGD:6480464 | CTD | |
| G | Tacc2 | transforming, acidic coiled-coil containing protein 2 |
|
multiple interactions | ISO | 1 | 189,894,937 | 190,085,789 | RGD:6480464 | CTD | |
| G | Taf9 | TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
|
decreases expression | ISO | 2 | 31,454,557 | 31,466,611 | RGD:6480464 | CTD | |
| G | Taok3 | TAO kinase 3 |
|
increases expression | ISO | 12 | 40,502,499 | 40,583,816 | RGD:6480464 | CTD | |
| G | Tars | threonyl-tRNA synthetase |
|
decreases expression | ISO | 2 | 60,765,899 | 60,784,665 | RGD:6480464 | CTD | |
| G | Tbx2 | T-box 2 |
|
increases expression | ISO | 10 | 74,085,203 | 74,092,988 | RGD:6480464 | CTD | |
| G | Tbxa2r | thromboxane A2 receptor |
|
multiple interactions | ISO | 7 | 9,867,739 | 9,872,536 | RGD:6480464 | CTD | |
| G | Tceb2 | transcription elongation factor B (SIII), polypeptide 2 |
|
decreases expression | ISO | 10 | 13,084,817 | 13,089,619 | RGD:6480464 | CTD | |
| G | Tcp1 | t-complex 1 |
|
affects expression | EXP | 1 | 42,103,543 | 42,111,222 | RGD:6480464 | CTD | |
| G | Tert | telomerase reverse transcriptase |
|
multiple interactions | ISO | 1 | 30,445,180 | 30,465,942 | RGD:6480464 | CTD | |
| G | Tert | telomerase reverse transcriptase |
|
increases expression | ISO | 1 | 30,445,180 | 30,465,942 | RGD:6480464 | CTD | |
| G | Tert | telomerase reverse transcriptase |
|
increases phosphorylation | ISO | 1 | 30,445,180 | 30,465,942 | RGD:6480464 | CTD | |
| G | Tert | telomerase reverse transcriptase |
|
multiple interactions | EXP | 1 | 30,445,180 | 30,465,942 | RGD:6480464 | CTD | |
| G | Tfam | transcription factor A, mitochondrial |
|
multiple interactions | ISO | 20 | 18,100,629 | 18,112,682 | RGD:6480464 | CTD | |
| G | Tfam | transcription factor A, mitochondrial |
|
increases expression | ISO | 20 | 18,100,629 | 18,112,682 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
affects binding | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
decreases expression | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
decreases expression | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff1 | trefoil factor 1 |
|
multiple interactions | ISO | 20 | 9,526,674 | 9,530,534 | RGD:6480464 | CTD | |
| G | Tff3 | trefoil factor 3, intestinal |
|
affects expression | ISO | 20 | 9,469,888 | 9,474,604 | RGD:6480464 | CTD | |
| G | Tff3 | trefoil factor 3, intestinal |
|
decreases expression | ISO | 20 | 9,469,888 | 9,474,604 | RGD:6480464 | CTD | |
| G | Tfpi | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
|
multiple interactions | ISO | 3 | 67,654,389 | 67,697,178 | RGD:6480464 | CTD | |
| G | Tgfa | transforming growth factor alpha |
|
multiple interactions | ISO | 4 | 120,355,649 | 120,437,772 | RGD:6480464 | CTD | |
| G | Tgfb1 | transforming growth factor, beta 1 |
|
multiple interactions | ISO | 1 | 80,894,705 | 80,911,020 | RGD:6480464 | CTD | |
| G | Tgfb2 | transforming growth factor, beta 2 |
|
affects expression | ISO | 13 | 102,718,703 | 102,818,768 | RGD:6480464 | CTD | |
| G | Tgfb2 | transforming growth factor, beta 2 |
|
multiple interactions | ISO | 13 | 102,718,703 | 102,818,768 | RGD:6480464 | CTD | |
| G | Tgfb2 | transforming growth factor, beta 2 |
|
multiple interactions | ISO | 13 | 102,718,703 | 102,818,768 | RGD:6480464 | CTD | |
| G | Tgfb3 | transforming growth factor, beta 3 |
|
multiple interactions | ISO | 6 | 110,173,443 | 110,195,215 | RGD:6480464 | CTD | |
| G | Tgfb3 | transforming growth factor, beta 3 |
|
affects expression | ISO | 6 | 110,173,443 | 110,195,215 | RGD:6480464 | CTD | |
| G | Tgfbi | transforming growth factor, beta induced |
|
multiple interactions | ISO | 17 | 13,904,882 | 13,935,110 | RGD:6480464 | CTD | |
| G | Tgfbi | transforming growth factor, beta induced |
|
affects expression | ISO | 17 | 13,904,882 | 13,935,110 | RGD:6480464 | CTD | |
| G | Tgfbr2 | transforming growth factor, beta receptor II |
|
affects expression | ISO | 8 | 120,593,595 | 120,680,453 | RGD:6480464 | CTD | |
| G | Tgm2 | transglutaminase 2, C polypeptide |
|
affects expression | ISO | 3 | 148,832,866 | 148,862,385 | RGD:6480464 | CTD | |
| G | Thbs1 | thrombospondin 1 | increases expression | ISO | RGD:6480464 | CTD | |||||
| G | Thbs2 | thrombospondin 2 |
|
decreases expression | ISO | 1 | 53,584,406 | 53,613,652 | RGD:6480464 | CTD | |
| G | Thy1 | Thy-1 cell surface antigen |
|
affects expression | ISO | 8 | 47,027,721 | 47,031,857 | RGD:6480464 | CTD | |
| G | Thy1 | Thy-1 cell surface antigen |
|
increases expression | EXP | 8 | 47,027,721 | 47,031,857 | RGD:6480464 | CTD | |
| G | Timp1 | TIMP metallopeptidase inhibitor 1 |
|
increases expression | ISO | X | 12,542,496 | 12,547,094 | RGD:6480464 | CTD | |
| G | Timp1 | TIMP metallopeptidase inhibitor 1 |
|
affects expression | EXP | X | 12,542,496 | 12,547,094 | RGD:6480464 | CTD | |
| G | Tiparp | TCDD-inducible poly(ADP-ribose) polymerase |
|
multiple interactions | ISO | 2 | 155,312,341 | 155,339,357 | RGD:6480464 | CTD | |
| G | Tle1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) |
|
affects expression | ISO | 5 | 89,682,837 | 89,765,682 | RGD:6480464 | CTD | |
| G | Tmem158 | transmembrane protein 158 |
|
affects expression | ISO | 8 | 128,037,014 | 128,038,012 | RGD:6480464 | CTD | |
| G | Tmem158 | transmembrane protein 158 |
|
multiple interactions | ISO | 8 | 128,037,014 | 128,038,012 | RGD:6480464 | CTD | |
| G | Tmod1 | tropomodulin 1 |
|
affects expression | ISO | 5 | 62,578,142 | 62,668,760 | RGD:6480464 | CTD | |
| G | Tmod1 | tropomodulin 1 |
|
multiple interactions | ISO | 5 | 62,578,142 | 62,668,760 | RGD:6480464 | CTD | |
| G | Tmpo | thymopoietin |
|
decreases expression | ISO | 7 | 28,086,576 | 28,111,800 | RGD:6480464 | CTD | |
| G | Tmprss3 | transmembrane protease, serine 3 |
|
multiple interactions | ISO | 20 | 9,545,077 | 9,564,261 | RGD:6480464 | CTD | |
| G | Tnc | tenascin C | affects expression | ISO | RGD:6480464 | CTD | |||||
| G | Tnc | tenascin C | multiple interactions | ISO | RGD:6480464 | CTD | |||||
| G | Tnf | tumor necrosis factor |
|
decreases expression | ISO | 20 | 3,661,000 | 3,663,618 | RGD:6480464 | CTD | |
| G | Tnfrsf11a | tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
|
decreases expression | ISO | 13 | 11,958,002 | 12,014,371 | RGD:6480464 | CTD | |
| G | Tnfrsf11b | tumor necrosis factor receptor superfamily, member 11b |
|
multiple interactions | ISO | 7 | 90,606,424 | 90,634,431 | RGD:6480464 | CTD | |
| G | Tnfrsf11b | tumor necrosis factor receptor superfamily, member 11b |
|
decreases expression | ISO | 7 | 90,606,424 | 90,634,431 | RGD:6480464 | CTD | |
| G | Tnfrsf11b | tumor necrosis factor receptor superfamily, member 11b |
|
multiple interactions | ISO | 7 | 90,606,424 | 90,634,431 | RGD:6480464 | CTD | |
| G | Tnfrsf11b | tumor necrosis factor receptor superfamily, member 11b |
|
increases expression | ISO | 7 | 90,606,424 | 90,634,431 | RGD:6480464 | CTD | |
| G | Tnfrsf11b | tumor necrosis factor receptor superfamily, member 11b |
|
increases expression | ISO | 7 | 90,606,424 | 90,634,431 | RGD:6480464 | CTD | |
| G | Tnfrsf21 | tumor necrosis factor receptor superfamily, member 21 |
|
multiple interactions | ISO | 9 | 13,587,961 | 13,666,380 | RGD:6480464 | CTD | |
| G | Tnfrsf25 | tumor necrosis factor receptor superfamily, member 25 |
|
decreases expression | ISO | 5 | 169,344,695 | 169,348,961 | RGD:6480464 | CTD | |
| G | Tnfsf11 | tumor necrosis factor (ligand) superfamily, member 11 |
|
decreases expression | ISO | 15 | 59,397,837 | 59,428,014 | RGD:6480464 | CTD | |
| G | Tnfsf11 | tumor necrosis factor (ligand) superfamily, member 11 |
|
decreases expression | ISO | 15 | 59,397,837 | 59,428,014 | RGD:6480464 | CTD | |
| G | Tnfsf15 | tumor necrosis factor (ligand) superfamily, member 15 |
|
increases expression | ISO | 5 | 80,700,180 | 80,716,158 | RGD:6480464 | CTD | |
| G | Tnik | TRAF2 and NCK interacting kinase |
|
multiple interactions | ISO | 2 | 115,599,466 | 116,003,005 | RGD:6480464 | CTD | |
| G | Tnni3 | troponin I type 3 (cardiac) |
|
affects expression | EXP | 1 | 68,028,198 | 68,031,882 | RGD:6480464 | CTD | |
| G | Tnpo1 | transportin 1 |
|
decreases expression | ISO | 2 | 29,482,093 | 29,539,145 | RGD:6480464 | CTD | |
| G | Tns3 | tensin 3 |
|
multiple interactions | ISO | 14 | 88,999,003 | 89,182,348 | RGD:6480464 | CTD | |
| G | Tns3 | tensin 3 |
|
multiple interactions | ISO | 14 | 88,999,003 | 89,182,348 | RGD:6480464 | CTD | |
| G | Tob1 | transducer of ErbB-2.1 |
|
multiple interactions | ISO | 10 | 82,852,405 | 82,854,443 | RGD:6480464 | CTD | |
| G | Tom1 | target of myb1 (chicken) |
|
affects expression | ISO | 19 | 13,890,549 | 13,925,393 | RGD:6480464 | CTD | |
| G | Top1 | topoisomerase (DNA) I |
|
decreases expression | ISO | 3 | 151,428,931 | 151,512,884 | RGD:6480464 | CTD | |
| G | Top2b | topoisomerase (DNA) II beta | decreases expression | ISO | RGD:6480464 | CTD | |||||
| G | Tp53i11 | tumor protein p53 inducible protein 11 |
|
affects expression | ISO | 3 | 77,587,546 | 77,602,708 | RGD:6480464 | CTD | |
| G | Tp53inp1 | tumor protein p53 inducible nuclear protein 1 |
|
multiple interactions | ISO | 5 | 25,008,253 | 25,014,263 | RGD:6480464 | CTD | |
| G | Tp73 | tumor protein p73 |
|
decreases expression | ISO | 5 | 170,848,979 | 171,078,739 | RGD:6480464 | CTD | |
| G | Tpm1 | tropomyosin 1, alpha |
|
affects expression | EXP | 8 | 71,331,304 | 71,358,063 | RGD:6480464 | CTD | |
| G | Tpm1 | tropomyosin 1, alpha |
|
affects expression | ISO | 8 | 71,331,304 | 71,358,063 | RGD:6480464 | CTD | |
| G | Traf3ip2 | Traf3 interacting protein 2 |
|
multiple interactions | ISO | 20 | 43,747,622 | 43,792,255 | RGD:6480464 | CTD | |
| G | Trak2 | trafficking protein, kinesin binding 2 |
|
decreases expression | ISO | 9 | 57,474,682 | 57,540,751 | RGD:6480464 | CTD | |
| G | Trib1 | tribbles homolog 1 (Drosophila) |
|
multiple interactions | ISO | 7 | 96,442,239 | 96,448,785 | RGD:6480464 | CTD | |
| G | Trib2 | tribbles homolog 2 (Drosophila) |
|
affects expression | ISO | 6 | 39,474,243 | 39,496,718 | RGD:6480464 | CTD | |
| G | Trim25 | tripartite motif-containing 25 |
|
multiple interactions | ISO | 10 | 77,459,844 | 77,488,383 | RGD:6480464 | CTD | |
| G | Trim36 | tripartite motif-containing 36 |
|
multiple interactions | ISO | 18 | 40,329,191 | 40,356,113 | RGD:6480464 | CTD | |
| G | Txnip | thioredoxin interacting protein |
|
multiple interactions | ISO | 2 | 191,356,954 | 191,360,757 | RGD:6480464 | CTD | |
| G | Txnrd1 | thioredoxin reductase 1 |
|
decreases expression | ISO | 7 | 23,055,544 | 23,093,815 | RGD:6480464 | CTD | |
| G | Ubb | ubiquitin B |
|
affects expression | EXP | 10 | 139,578,694 | 139,579,068 | RGD:6480464 | CTD | |
| G | Ube3c | ubiquitin protein ligase E3C |
|
decreases expression | ISO | 4 | 889,640 | 991,900 | RGD:6480464 | CTD | |
| G | Ung | uracil-DNA glycosylase |
|
decreases expression | ISO | 12 | 43,520,629 | 43,528,873 | RGD:6480464 | CTD | |
| G | Usp32 | ubiquitin specific peptidase 32 |
|
decreases expression | ISO | 10 | 73,256,761 | 73,374,747 | RGD:6480464 | CTD | |
| G | Vdr | vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
multiple interactions | ISO | 7 | 136,567,614 | 136,617,280 | RGD:6480464 | CTD | |
| G | Vdr | vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
affects response to substance | ISO | 7 | 136,567,614 | 136,617,280 | RGD:6480464 | CTD | |
| G | Vdr | vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
affects response to substance | ISO | 7 | 136,567,614 | 136,617,280 | RGD:6480464 | CTD | |
| G | Vegfa | vascular endothelial growth factor A |
|
multiple interactions | ISO | 9 | 10,520,730 | 10,536,071 | RGD:6480464 | CTD | |
| G | Vegfa | vascular endothelial growth factor A |
|
increases expression | ISO | 9 | 10,520,730 | 10,536,071 | RGD:6480464 | CTD | |
| G | Vwf | von Willebrand factor |
|
increases expression | ISO | 4 | 161,723,415 | 161,854,766 | RGD:6480464 | CTD | |
| G | Wdr1 | WD repeat domain 1 |
|
affects expression | ISO | 14 | 77,489,828 | 77,524,430 | RGD:6480464 | CTD | |
| G | Wfdc1 | WAP four-disulfide core domain 1 |
|
increases expression | EXP | 19 | 49,924,440 | 49,943,113 | RGD:6480464 | CTD | |
| G | Wnt11 | wingless-type MMTV integration site family, member 11 |
|
decreases expression | ISO | 1 | 156,125,969 | 156,142,065 | RGD:6480464 | CTD | |
| G | Wnt5a | wingless-type MMTV integration site family, member 5A |
|
multiple interactions | ISO | 16 | 3,782,025 | 3,799,625 | RGD:6480464 | CTD | |
| G | Wwc1 | WW and C2 domain containing 1 |
|
affects expression | ISO | 10 | 20,750,770 | 20,910,298 | RGD:6480464 | CTD | |
| G | Xdh | xanthine dehydrogenase |
|
increases activity | ISO | 6 | 21,417,685 | 21,590,015 | RGD:6480464 | CTD | |
| G | Xdh | xanthine dehydrogenase |
|
multiple interactions | ISO | 6 | 21,417,685 | 21,590,015 | RGD:6480464 | CTD | |
| G | Xpo1 | exportin 1, CRM1 homolog (yeast) |
|
decreases expression | ISO | 14 | 103,943,249 | 103,978,717 | RGD:6480464 | CTD | |
| G | Xrcc5 | X-ray repair complementing defective repair in Chinese hamster cells 5 |
|
decreases expression | ISO | 9 | 71,472,459 | 71,581,936 | RGD:6480464 | CTD | |
| G | Ybx3 | Y box binding protein 3 |
|
affects expression | EXP | 4 | 169,076,517 | 169,099,849 | RGD:6480464 | CTD | |
| G | Zak | sterile alpha motif and leucine zipper containing kinase AZK |
|
decreases expression | ISO | 3 | 54,767,724 | 54,915,022 | RGD:6480464 | CTD | |
| G | Zcchc24 | zinc finger, CCHC domain containing 24 |
|
affects expression | ISO | 16 | 1,310,191 | 1,361,259 | RGD:6480464 | CTD | |
| G | Zcchc24 | zinc finger, CCHC domain containing 24 |
|
multiple interactions | ISO | 16 | 1,310,191 | 1,361,259 | RGD:6480464 | CTD | |
| G | Zeb1 | zinc finger E-box binding homeobox 1 |
|
decreases expression | ISO | 17 | 60,177,150 | 60,198,584 | RGD:6480464 | CTD | |
| G | Zfp36 | zinc finger protein 36 |
|
multiple interactions | ISO | 1 | 83,486,643 | 83,489,123 | RGD:6480464 | CTD | |
| G | Zfp36 | zinc finger protein 36 |
|
affects expression | ISO | 1 | 83,486,643 | 83,489,123 | RGD:6480464 | CTD | |
| G | Zfp395 | zinc finger protein 395 |
|
multiple interactions | ISO | 15 | 44,806,300 | 44,819,787 | RGD:6480464 | CTD | |
| G | Zmiz1 | zinc finger, MIZ-type containing 1 |
|
affects expression | ISO | 16 | 1,037,882 | 1,245,259 | RGD:6480464 | CTD | |
| G | Zmiz1 | zinc finger, MIZ-type containing 1 |
|
multiple interactions | ISO | 16 | 1,037,882 | 1,245,259 | RGD:6480464 | CTD | |
| G | Zmym2 | zinc finger, MYM-type 2 |
|
increases expression | ISO | 15 | 35,905,999 | 35,979,468 | RGD:6480464 | CTD | |
Term paths to the root
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term